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SEQUESTERED ALKALOID DEFENSES IN THE DENDROBATID POISON FROG
OOPHAGA PUMILIO PROVIDE VARIABLE PROTECTION FROM MICROBIAL PATHOGENS

ABSTRACT
Amphibians produce the majority of their defensive chemicals, however alkaloid
defenses in poison frogs are sequestered from dietary arthropods. Alkaloids function as a
defense against predators, and certain types appear to inhibit microbial growth. However,
alkaloid defenses vary considerably among populations of poison frogs, reflecting
geographic

differences

in

availability

of

dietary

arthropods.

Consequently,

environmentally driven differences in poison frog alkaloid defenses may have significant
implications regarding their protection against pathogens. While natural alkaloid mixtures
in poison frogs have recently been shown to inhibit growth of non-pathogenic microbes,
no studies have examined the effectiveness of alkaloids against microbes that infect
frogs. Herein, I examined how alkaloid defenses in the strawberry poison frog, Oophaga
pumilio, affect growth of the known anuran pathogens Aeromonas hydrophila and
Klebsiella pneumoniae. Frogs were collected from five locations throughout Costa Rica
that are known to vary in their alkaloid profiles. Alkaloids were isolated from individual
skins, and extracts were assayed against both pathogens. Microbe subcultures were
inoculated with extracted alkaloids to create dose-response curves. Subsequent
spectrophotometry and cell counting assays were used to assess growth inhibition. GCMS was used to characterize and quantify alkaloids in frog extracts, and my results
suggest that variation in alkaloid defenses lead to differences in inhibition of these
pathogens. This study provides the first evidence that alkaloid variation in a dendrobatid
1

poison frog is associated with differences in inhibition of anuran pathogens, and offers
further support that alkaloid defenses in poison frogs confer protection against both
pathogens and predators.

2

INTRODUCTION
Predation and disease are important selective pressures that affect individuals,
populations, and communities, thereby driving the evolution of highly diversified
defensive strategies (Edmunds, 1974). Among these strategies, the use of unpalatable or
toxic compounds as a defense mechanism is a common adaptation present in a variety of
microorganisms, plants, invertebrates, and vertebrates (reviewed in Wolfe, 2000; Mebs,
2001; Engel et al., 2002; Fürstenberg-Hägg et al., 2013). Among vertebrates, chemical
defenses are widely known for protecting against predators, but in some cases, they also
play a critical role in defending against pathogenic microorganisms (Nicolas and Mor,
1995). Amphibians, for example, have characteristically thin, permeable integuments and
often inhabit moist environments that favor the growth of bacteria and fungi; as a result,
many amphibians have developed defensive systems primarily based on chemicals
(Bevins and Zasloff, 1990; Nicolas and Mor, 1995; Conlon, 2011a).
All amphibians have dermal granular glands, which develop during late larval
stages and proliferate in size and number throughout the integument after metamorphosis
(Vanable, 1964; Toledo and Jared, 1995). Granular glands are syncytial structures
enveloped by smooth muscle cells and connected to the epidermis via ducts (Dockray and
Hopkins, 1975; Neuwirth et al., 1979; Toledo and Jared, 1995). These glands are
responsible for releasing skin secretions (i.e., chemicals) intended to defend against
predators, parasites, and pathogens (Toledo and Jared, 1995; Rivas et al., 2009; Conlon,
2011a, 2011b; Savitzky et al., 2012). Accordingly, amphibian granular glands secrete a
wide variety of bioactive chemicals in response to stimulation by stress or injury (Toledo
and Jared, 1995; Roelants et al., 2013), including biogenic amines (Daly et al., 1987;
3

Erspamer, 1994; McClean et al., 2002), peptides and proteins (Rollins-Smith, 2005;
Conlon, 2011a, 2011b), steroidal bufadienolides (Daly et al., 2004; Erspamer, 1994),
tetrodotoxin and related analogs (Yotsu et al., 1990; Kim et al., 2003; Cardall et al.,
2004; Daly, 2004; Yotsu-Yamashita et al., 2004), indolic alkaloids (Daly and Garraffo,
1990; Jeckel et al., 2015a), and an array of lipophilic alkaloids (Daly et al., 2005;
Saporito et al., 2012). Amphibians synthesize the majority of these chemical defenses
(Daly, 1995; Toledo and Jared, 1995), but some antimicrobial peptides and metabolites
are provided by microbial symbionts (Brucker et al., 2008; Harris et al., 2009; Becker
and Harris, 2010; Loudon et al., 2014), and lipophilic alkaloids are acquired through diet
(Daly et al., 1994; Saporito et al., 2009). While thousands of unique compounds have
been identified from amphibian skin secretions over the past several decades (Erspamer,
1994; Daly, 1995; Daly et al., 2005; Xu and Lai, 2015), research has focused largely on
synthesized (i.e., antimicrobial peptides) rather than acquired defenses.
Peptides are well-studied and commonly synthesized defensive compounds
secreted by the majority of amphibians (Bevins and Zasloff, 1990; Pukala et al., 2006).
Some peptides play a role in protecting against predators and parasites (Spindel, 2006;
König et al., 2012), and many are considered key components in the amphibian innate
immune system due to their broad-spectrum antimicrobial activities (Nicolas and Mor,
1995; Diamond et al., 2009; Conlon, 2011b). Antimicrobial peptides are amphipathic,
cationic peptides that are 10-50 amino acid residues in length and express cytolytic
activity against pathogenic bacteria, fungi, viruses, and protozoa (Nicolas and Mor, 1995;
Conlon, 2011b). Approximately 1,900 antimicrobial peptides, classified into nearly 100
families, have been identified from 178 amphibian species in 28 genera (reviewed in Xu
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and Lai, 2015). At the species level, amphibian skin secretions often contain multiple
members of a single peptide family (Tennessen and Blouin, 2007); the heterogeneity of
molecular structure among peptides within each family is substantial, and this is reflected
in the observed variation of antimicrobial activity and microbe specificity between
peptides (Tennessen et al., 2009; Conlon, 2011a). The diversity of peptides produced by
individual amphibian species may confer protection against a wider range of microbes
compared to those that produce relatively homogenous mixtures, and interactive effects
between peptides may increase antimicrobial efficacy (Nicolas and Mor, 1995; Simmaco
et al., 1998b; Zasloff, 2002; Rosenfeld et al., 2006). Not all amphibians secrete
synthesized antimicrobial peptides, but in general, those that do secrete peptides appear to
have an advantage in terms of protection from infection (Conlon, 2011b). In contrast,
amphibians that rely on external and unpredictable sources for defensive compounds
(e.g., lipophilic alkaloids) are only able to sequester what is available to them, which may
influence their protection from predators and pathogens (Mina et al., 2015). Lipophilic
alkaloids represent a suite of acquired chemical defenses that are, in many ways,
analogous to the diversity of synthesized peptide defenses present in many amphibians.
Moreover, lipophilic alkaloid defenses provide an opportunity to examine the
antimicrobial efficacy of sequestered chemical defenses, which has gone largely
unstudied.
Poison frogs are a polyphyletic group of brightly-colored anurans that accumulate
and secrete lipophilic alkaloids sequestered from their diet as a defense. This globallydistributed assemblage is represented by approximately 150 species from seven lineages
in the families Bufonidae (Melanophryniscus), Dendrobatidae (alkaloid sequestration
5

evolved

independently

in

Dendrobatinae,

Ameerega,

and

Epipedobates),

Eleutherodactylidae (Eleutherodactylus), Mantellidae (Mantella), and Myobatrachidae
(Pseudophryne) (reviewed in Saporito et al., 2012). Experimental evidence of alkaloid
sequestration in bufonids (Hantak et al., 2013), dendrobatids (Daly et al., 1994),
mantellids (Daly et al., 1997), and myobatrachids (Smith et al., 2002) suggests that
poison frogs uptake and store an assortment of lipophilic alkaloids (i.e., alkaloid
cocktails) obtained from alkaloid-containing dietary arthropods. In particular, mites and
ants provide the majority of alkaloids identified in poison frogs (Daly et al., 2002;
Saporito et al., 2004, 2007b, 2009; Takada et al., 2005), though certain classes of
alkaloids may also be derived from coccinellid beetles (Daloze et al., 1995) and
siphonotid millipedes (Saporito et al., 2003). The lipophilic alkaloids that poison frogs
sequester from arthropods are numerous and highly diverse, with over 1,200 unique
alkaloids identified and separated into 28 different structural classes (Daly et al., 2005;
Garraffo et al., 2012; Saporito et al., 2012; Jeckel et al., 2015a). Individual poison frogs
accumulate between one and 69 of these distinct alkaloids in varying amounts (Daly et
al., 2005; Saporito et al., 2006, 2007a; Mina et al., 2015), although there is no known
maximum number that can be accumulated; conversely, dendrobatid poison frogs are not
known to synthesize antimicrobial peptides, although trace amounts of the peptide
carnosine have been detected in one species of dendrobatid poison frog to date (Daly et
al., 1984, 1987; Erspamer et al., 1986; Prates et al., 2012; see Jeckel et al., 2015a for
review). Just as producing a variety of peptides enhances protection from a wider range
of pathogens (Rosenfeld et al., 2006; Conlon, 2011b), more diverse alkaloid cocktails
may provide protection from a wider range of pathogens, though this has yet to be tested.
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Alkaloids in poison frogs appear to function as a defense against predators
primarily due to their unpalatability, and in some cases, toxicity (Brodie and Tumbarello,
1978; Stynoski et al., 2014; Hantak et al., 2016; Murray et al., 2016). Additionally, they
may confer protection against pathogenic microorganisms. For example, the presence of
alkaloids throughout non-integumentary tissue (including muscle and liver tissues, as
well as oocytes) in the same relative proportions as in the skin of the bufonid poison frog,
Melanophryniscus simplex, may indicate that alkaloids play a role in protection from
internal infection by non-integumentary parasites (Grant et al., 2012). An alkaloid found
commonly in some dendrobatid poison frogs, pumiliotoxin 251D, may also be a highly
effective deterrent of a tropical mosquito known to parasitize anurans (Weldon et al.,
2006). Furthermore, individual synthetic and natural alkaloids inhibit the growth of
common microbes, including the bacteria Bacillus subtilis (gram-negative) and
Escherichia coli (gram-positive), and the fungus Candida albicans (Macfoy et al., 2005).
Most recently, natural alkaloid cocktails from geographically separate populations of the
dendrobatid poison frog, Oophaga pumilio, were found to inhibit growth of those same
common microbes to varying degrees, suggesting that alkaloid defenses may vary among
populations in their ability to inhibit microbial growth (Mina et al., 2015).
The individual alkaloids evaluated for antimicrobial activity by Macfoy et al.
(2005) were primarily synthetic enantiomers of poison frog alkaloids, although some
individual natural alkaloids were included. In general, piperidine, pumiliotoxin, and
pyrrolidine alkaloids were the most inhibitory, and individual alkaloids were most
effective against B. subtilis and C. albicans, but rarely effective against E. coli (Macfoy
et al., 2005). Antimicrobial assays testing natural alkaloid cocktails from different
7

populations of O. pumilio, on the other hand, suggest that the bacteria B. subtilis and E.
coli are more effectively inhibited by alkaloid defenses than the fungus C. albicans (Mina
et al., 2015). While this may indicate that natural alkaloid defenses of O. pumilio are less
effective at inhibiting fungal microbes, the ecological relevance of this is unknown as the
microbes tested were not frog pathogens.
Alkaloid defenses vary considerably among dendrobatid poison frog species,
populations, and individuals within populations, but geographically close populations
generally have more similar alkaloid defenses than geographically distant populations
(Myers and Daly, 1976; Daly et al., 1987, 2008a; Saporito et al., 2006, 2007a). Although
certain factors such as species, sex, age, and life stage are important determinants of
alkaloid variation (Saporito et al., 2010a, 2010b, 2012; Stynoski et al., 2014; Jeckel et al.,
2015b), geographic differences in alkaloid defenses seem to be a direct result of variation
in the local availability of dietary arthropods (Saporito et al., 2007a). Given that
antimicrobial activity differs among individual alkaloids (Macfoy et al., 2005) and
natural alkaloid cocktails (Mina et al., 2015), environmentally-driven differences in
alkaloid defenses may influence frog protection against natural pathogens at the
population level. For example, differential resistance among poison frog populations to
infectious pathogens may correlate with survival probability during outbreaks of
emerging infectious diseases. Moreover, the combination of geographic and temporal
differences in pathogen prevalence and variable pathogen protection among poison frog
populations may influence species distributions and persistence in the wild. Poison frogs
in captivity may be even more vulnerable since alkaloids are acquired exclusively
through a specialized diet of alkaloid-containing arthropods (Daly et al., 1994; Saporito
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et al., 2009); frogs entirely lack defenses if raised in captivity (Daly et al., 1992, 1997;
Hantak et al., 2013), while frogs collected from nature are left with only the alkaloids
contained in their granular glands at the time of collection, which can persist for over six
years in captivity (Myers et al., 1978; St. Claire et al., 2005). As a result of global
amphibian population declines, ex situ captive breeding programs with the goal of
facilitating successful reintroductions to the wild have been initiated for a variety of
endangered amphibians (for review, see Griffiths and Pavajeau, 2008; Harding et al.,
2015), some involving endangered poison frogs (Hunter et al., 2010b; McFadden et al.,
2013; Edmonds et al., 2015). If poison frogs with reduced or absent alkaloid defenses are
truly more vulnerable to infectious pathogens, captive breeding programs for poison frogs
may greatly benefit from research that informs management and reintroduction strategies
that are more likely to succeed, which is crucial in light of contemporary biodiversity loss
and the global amphibian crisis.
Population declines and species extinctions resulting in losses of biodiversity are
occurring at rates that are orders of magnitude higher than the average rate inferred from
the fossil record (Myers, 1993; Singh, 2002). Of all vertebrate taxa, amphibians are
experiencing the greatest global biodiversity decline (Stuart et al., 2004), and although
there are many contributing factors (Blaustein and Kiesecker, 2002), infectious disease
appears to be a major cause (Daszak et al., 1999). Numerous pathogenic microbes infect
amphibians, including opportunistic gram-negative bacteria, the chytrid fungus
Batrachochytrium dendrobatidis (Bd), mycobacteria, ranaviruses, water molds,
trematodes, and other various parasites (Taylor et al., 2001; Green et al., 2002; Densmore
and Green, 2007; Schadich and Cole, 2010; Haridy et al., 2014). While the majority of
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research on amphibian disease in relation to population declines to date has focused on
Bd, other pathogens are involved as well and have been comparatively understudied (see
Green et al., 2002; Prada-Salcedo et al., 2011). For example, Aeromonas hydrophila,
ranaviruses, mycobacteria, and water molds are reported to co-occur with chytrid
infections in captive and wild populations of frogs (Miller et al., 2008; Hill et al., 2010;
Prada-Salcedo et al., 2011; Whitfield et al., 2013); therefore, understanding how
amphibians deal with these other pathogens alone or in co-infection with Bd will provide
valuable insight into the role of these microbes in amphibian declines.
Opportunistic gram-negative bacteria can cause bacterial dermatosepticemia, a
fatal systemic infectious disease in frogs that is implicated in population declines and
extirpations in the wild (Hunsaker and Potter, 1960; Nyman, 1986; Bradford, 1991;
Sherman and Morton, 1993) and mass mortalities in captivity (Olson et al., 1992;
Pearson, 1998; Green et al., 1999; Mauel et al., 2002). Although a variety of gramnegative bacteria can cause bacterial dermatosepticemia, certain bacteria seem to be
implicated in the majority of cases (e.g., A. hydrophila). Some bacteria also appear to be
more virulent than others, dependent on frog species as well as a variety of
environmental, stress, dietary, health, and immune status factors (Schadich and Cole,
2010). For instance, Schadich and Cole (2010) isolated A. hydrophila, Klebsiella
pneumoniae, and Proteus mirabilis from brown tree frogs (Litoria ewingii) during an
outbreak of bacterial dermatosepticemia in a New Zealand forest; through exposure of
healthy frogs to the three pathogen isolates, K. pneumoniae was determined to be the
most pathogenic, despite A. hydrophila typically being the reported causative agent in
bacterial dermatosepticemia epidemics. Moreover, L. ewingii lacks skin peptide defenses
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(Schadich, 2009), which supports the idea that chemical defenses in frogs are important
for protection from these pathogens, considering how susceptible to infection L. ewingii
appears to be. For instance, resistance of Litoria raniformis to K. pneumoniae is related to
the antimicrobial activity of its peptide defenses (Schadich et al., 2009), and resistance of
certain Australian and Central American frogs to Bd is correlated with the antimicrobial
activity of peptides (Woodhams et al., 2006a, 2006b, 2007a). Although antimicrobial
peptide defenses are thought to have evolved as a secondary, broad-spectrum immune
defense (Nicolas and Mor, 1995; Roelants et al., 2013) and are effective in that role
(Simmaco et al., 1998b; Zasloff, 2002; Rollins-Smith, 2005), there is a fundamental gap
in our understanding of the role that sequestered alkaloid defenses serve in defending
poison frogs from infection.
Research on the antimicrobial activity of alkaloid defenses in frogs (Macfoy et al.,
2005; Mina et al., 2015) has focused on the strawberry poison frog, O. pumilio, a
terrestrial dendrobatid frog whose alkaloid defenses are relatively well-characterized and
vary considerably with geographic location at both small and large spatial scales
(Saporito et al., 2006, 2007a, 2010a). Moreover, although O. pumilio is not at risk for
decline due to infectious pathogens, individual and co-occurring infections by pathogenic
microbes are prevalent in certain populations (Whitfield et al., 2013). The substantial
variability in O. pumilio alkaloid defenses, in addition to an abundance of previouslyidentified alkaloids, makes O. pumilio an ideal study organism in which to examine
ecologically relevant antimicrobial activity of sequestered alkaloid defenses. The aim of
the present study is to examine the extent to which the variable alkaloid defenses in a
dendrobatid poison frog, Oophaga pumilio, inhibit the growth of the anuran pathogens A.
11

hydrophila and K. pneumoniae. Comparing highly variable alkaloid defenses from
individual O. pumilio with corresponding microbial inhibition allows direct evaluation of
the extent to which inhibition is driven by alkaloid defenses. On the basis of previous
studies, I hypothesized that population-level variation in alkaloid defenses will
differentially inhibit microbial growth, dependent upon the quantity and types of
alkaloids present. Specifically, populations with greater quantities of alkaloids and more
diverse alkaloid cocktails are predicted to inhibit microbial growth most effectively.

METHODS
Study Sites and Frog Collections
Adult frogs were collected from five sites located in lowland tropical rainforest
throughout eastern Costa Rica and were selected based on known differences in the
alkaloid defenses (i.e., number and quantity of unique alkaloids and alkaloid structural
classes) of O. pumilio from each site (Fig. 1; alkaloid data from Saporito et al., 2007a).
La Selva Biological Station (10°26' N, 83°59' W) and Finca los Nacientes (10°21’53” N,
84°8’6” W) are located in Heredia Province. La Selva is a private biological reserve
managed by the Organization for Tropical Studies, and is dominated by primary forest
that has experienced minimal human impact since the European colonization of the
Americas (Whitfield et al., 2012). The other three sites, Tortuguero (10°35’14” N,
83°31’34” W), Río Palmas (10°10’16” N, 83°36’26” W), and Gandoca (9°35’03” N,
82°37’13” W), are located throughout Limón Province, which spans the entire eastern
coast of Costa Rica.
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In order to acquire natural frog alkaloids for microbial growth assays, 14 adult O.
pumilio were collected from each of the five geographically isolated sites throughout
Costa Rica (n = 14 frogs per population, N = 70 total). This sample size allowed for
variation in alkaloid defenses to be examined within and among populations and between
sexes, and was based on the permission allowed by the government of Costa Rica. At
each site, a single 45 m × 45 m collection plot was established following the methods of
Saporito et al. (2006, 2007a, 2010). Selection of a single collection location at each site
minimized the variation in alkaloid samples obtained within populations since availability
of dietary arthropods varies geographically and since O. pumilio has a patchy distribution
throughout its range. Frogs within the delineated plot were collected using hand nets and
then sexed based on gular skin patches (Donnelly, 1989) until an even sex ratio of seven
males and seven females were acquired (except at Río Palmas and Finca Los Nacientes,
where eight males and six females were collected due to difficulty locating females).
Collected frogs were weighed to the nearest 0.01 g using a Pesola PPS200 digital
pocket scale, measured for snout-to-vent length (SVL) to the nearest 0.1 mm using
Control Company Traceable digital calipers, and then euthanized by freezing. Frog skins
were collected and stored individually in 4 mL of 100% methanol inside sealed glass
vials with Teflon-lined caps. Each vial was labeled with a unique identifier, allowing for
extracts to be tracked throughout experimentation and matched to their frog’s collection
location, sex, weight, and SVL. All methods were approved by John Carroll University
IACUC protocol #1101 and collection of O. pumilio was approved by CITES collection
permit 2015-CR1420/SJ(#S1487).
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Alkaloid Fractionations
Alkaloids from each of the 70 frog skins were extracted into individual 100 µL fractions
using an acid-base extraction technique that isolates lipophilic alkaloids from other
compounds such as fatty acids and carotenoids (original methods outlined in Saporito et
al., 2010). For each skin sample, 1 mL of the original 4 mL methanol extract was
transferred to a 10 mL conical vial and acidified with 50 µL hydrochloric acid (1 N) to
solubilize the alkaloids in water. This solution was then evaporated to a volume of 100
µL using nitrogen gas, followed by dilution with 200 µL deionized water. Four
subsequent extractions with 300 µL hexane removed the majority of non-alkaloid
lipophilic compounds from the samples. The organic hexane layer was disposed of, and
the remaining aqueous solution containing alkaloids was basified with eight drops of
sodium bicarbonate such that alkaloids became soluble in ethyl acetate. Once basicity
was verified with pH paper, three subsequent extractions with 300 µL ethyl acetate then
separated alkaloids from residual non-alkaloid compounds in the aqueous solution. Each
time, the ethyl acetate layer was pipetted into a tube with anhydrous sodium sulfate to
remove remaining trace amounts of water. The total 900 µL of ethyl acetate containing
alkaloids was transferred to a clean tube and evaporated until dryness with nitrogen gas.
Alkaloid fractions were immediately resuspended in 100 µL methanol as soon as all
liquid evaporated, and this 100 µL fraction was transferred to a microvial with a Teflonlined cap for use in microbial growth inhibition assays. Alkaloid extractions were
conducted twice for each frog skin (n = 140 individual fractionations), resulting in a final
volume of 200 µL alkaloids available for use in microbial growth inhibition assays. The
two 100 µL alkaloid fractions from each frog were combined to eliminate any variation
14

between fractions from the same frog skin, and then the alkaloid fractions from all frogs
were used in microbial growth inhibition assays (see below). For GC-MS analyses of
alkaloid fractions, this procedure was carried out one additional time for each skin sample
(n = 70 individual fractionations), but with the addition of 100 µL nicotine immediately
after the acidification step as an internal standard.

Culture and Maintenance of Microbes
All procedures involving microbial cultures and growth assays were performed in a
HEPA filtered laminar flow hood (SterilGARD Hood, The Baker Company, Sanford,
ME) with barrier pipet tips (AvantGuard, MIDSCI, St. Louis, MO), and all media was
sterilized before use by autoclaving at 121°C for 30 minutes. Aeromonas hydrophila
(ATCC® 35654™) and Klebsiella pneumoniae subsp. pneumoniae (ATCC® 13883™)
stock cultures were each grown in 50 mL polypropylene conical tubes (SpinMax,
Crystalgen, Commack, NY) containing 30 mL tryptic soy broth (TSB) (Remel, Thermo
Scientific, Lenexa, KS), and incubated for 24 hours at 30°C (A. hydrophila) or 37°C (K.
pneumoniae) in a shaking incubator (New Brunswick Scientific 12400 Incubator Shaker)
set to 100 revolutions per minute (rpm). All procedures involving incubation and/or
shaking were conducted under these temperature and agitation conditions. Twelve 1 mL
stock cultures per microbe were cryopreserved at -80°C (see Cryopreservation of
Microbes in APPENDIX). Each week, a 10 µL loop from a new thawed stock culture was
streaked on a tryptic soy agar (TSA) (Teknova, Hollister, CA) culture plate and incubated
until single colonies formed (typically 8 hours). This ensured viability of single colonies
that were used to grow cultures for microbial growth inhibition assays.
15

Microbial Growth Inhibition Assays
Optical Density Assays
Optical density (OD) assays were adapted from an assay described by Mina et al. (2015).
To begin each OD assay (n = 2 per population, 10 per microbe, 20 total), a 30 mL TSB
culture was inoculated with a single pure colony from a streak plate and incubated at
30°C (A. hydrophila) or 37°C (K. pneumoniae) for 18 hours. Based on pilot growth
experiments (see Pilot Experiments in APPENDIX), these cultures were diluted with TSB
to a ratio of 1:10 (A. hydrophila) or 1:5 (K. pneumoniae) immediately prior to
experimentation, allowing all assayed subcultures to proceed through the logarithmic
(log) growth phase and into the stationary growth phase within 24 hours. Diluted cultures
were vortexed (Vortex Genie 2, VWR, Radnor, PA) for 5 seconds and poured into a
plastic trough (VWR, Radnor, PA), and then equal 200 µL volumes (subcultures) of the
microbial suspension were immediately aliquotted into 80 wells of a 96-well microplate
(Falcon, Corning, Tewksbury, MA) using a multichannel pipettor (20 – 200 µL, BioPette
Plus, Labnet International, Edison, NJ).
Column 1 on the microplate represented an untreated control, columns 2 – 5 and 7
– 9 each represented one of seven individual frogs in the assay (inoculation with alkaloid
extracts from corresponding frogs), and columns 6 and 10 represented vehicle controls.
Methanol alone served as the vehicle control because alkaloid extracts were dissolved in
methanol. Excluding column 1, each of the 72 inoculated subcultures per assay were
inoculated with either 2.4 (rows A – D) or 4.8 µL (rows E – H) of alkaloid extract or pure
methanol. This resulted in a total of four replicates (subsamples) per volume under each
treatment (alkaloid or methanol inoculation), except for the untreated control that had
16

eight replicates in each assay. Since the addition of methanol resulted in consistent
growth inhibition, any subsamples that grew an abnormal amount (> 20%) more than
untreated controls were considered contaminated and were therefore excluded from
analyses. Treatment volumes were selected based on pilot experiments which indicated
that 9.6 µL of methanol in 200 µL of A. hydrophila was highly inhibitory and would
likely obscure any inhibition due to natural alkaloid extracts; while treatments with 2.4
µL and 4.8 µL of methanol were inhibitory compared to negative controls, differences
between methanol and alkaloid treatments were still apparent at these volumes (see Pilot
Experiments in APPENDIX). Moreover, the treatment volumes are ecologically relevant
for what microbes may be exposed to on frog skin, representing 0.6% and 1.2%,
respectively, of the total quantity of alkaloids present in individual frog skins (based on
calculations from Gronemeyer, 2013).
Immediately following inoculation, the microplate was placed in a Fisher
Scientific Multiskan FC microplate reader inside an incubator (Forma Reach-In
Incubator, Thermo Fisher Scientific, Marietta, OH) at the microbe’s corresponding
growth temperature. An initial measurement of each subculture’s OD at 620 nm (OD620)
was taken prior to incubation to ensure that subcultures in each assay started off at an OD
similar to those in pilot experiments (± 0.02 OD620 to account for random variation),
suggesting that they would be in mid-logarithmic (mid-log) growth phase. When initial
OD was verified, a 24.5-hour program that recorded OD620 of each subculture at 15minute intervals after shaking the plate at medium speed for five seconds was initiated to
create 24-hour growth curves for each treatment (see Appendices 11-30 for growth
curves). The final OD620 readings of all four subsamples per sample were averaged for
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use in statistical analyses of OD assays (except in six instances for A. hydrophila and one
instance for K. pneumoniae, when one subsample in each instance was removed due to
abnormal growth in 2.4 µL dose treatments). To equalize sample sizes among treatments,
fourteen of the twenty methanol control samples for each microbe were randomly
selected for use in statistical analyses.

Colony-forming unit assays
Colony-forming unit (CFU) assays were conducted to assess the viability of subcultures
that were exposed to natural alkaloid extracts and methanol treatments for 24 hours.
Immediately following the final measurement of OD assays, three randomly-selected
subsamples from each treatment (e.g., four wells inoculated with alkaloid extracts) were
used in CFU assays. Since some subsamples grew abnormally in pilot experiments (but
never more than one of four subsamples), three of four subsamples were randomly
selected for the final analysis. This approach also ensured equal sample sizes across
treatments.
To quantify viable bacteria in each treatment’s subsamples, each of the three
selected subsamples were serially-diluted in tenfold increments up to 10-7 using
microplates. Ten microliters of each serial dilution were then plated on TSA in square 6 ×
6 gridded petri dishes (Fisherbrand, Thermo Fisher Scientific, Waltham, MA) and
incubated for seven hours or until single colonies (i.e., colony-forming units) formed.
Once CFUs were visible, the number of CFUs at each dilution (10-1 – 10-7) for each
subsample was recorded. When CFU counts exceeded 30, colonies tended to grow into
one another and it became difficult to accurately quantify CFUs. Therefore, the serial
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dilution that grew CFUs nearest to 30 in number, while still being equal to or below 30,
was used to calculate the original cell density (OCD; CFU/mL; equation below) of each
subsample. The average of each treatment’s three subsample OCD values was used in
statistical analyses.

Original cell density (CFU/mL) =

(Colony-forming units)
(Dilution factor) × (Volume of aliquot in mL)

In the OCD equation, dilution factor refers to the magnitude of dilution of the quantified
aliquot (e.g., 10-7), and volume of aliquot in mL refers to the volume of each subsample’s
dilutions that were plated (10 µL in this case, or 0.01 mL).

Alkaloid Analysis
To determine which unique alkaloids were present in extracts, and in what quantities
(µg), samples of individual frog extracts containing a nicotine standard (1 µg/10 µL; (−)nicotine ≥99%, Sigma-Aldrich) were analyzed using gas chromatography-mass
spectrometry (GC-MS). For each alkaloid extract, multiple 1 µL aliquots were analyzed
with a Varian Saturn 2100T ion trap MS instrument coupled to a Varian 3900 GC (using
a 30 m x 0.25 mm i.d. Varian Factor Four VG-5ms fused silica column). GC-MS analysis
was carried out using a temperature program progressing from 100°C to 280°C
(increasing at a rate of 10°C/min) and with helium as the carrier gas (flow rate of 1
mL/min). Both electron impact (EI) MS and chemical ionization (CI) MS were used to
analyze samples of alkaloid fractions, with methanol as the CI reagent. In order to more
accurately estimate the quantity of alkaloids present in each frog’s alkaloid extract, EIMS was conducted in triplicate for each frog, while CI-MS was performed once for each
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frog. In total, four 1 µL samples from each of 70 frogs’ alkaloid extract were analyzed (n
= 280 GC-MS runs).
Unique alkaloids were identified from GC-MS output of alkaloid extracts by
comparing the GC retention times and mass spectra of individual peaks with alkaloids
previously identified and reported in poison frogs (Daly et al., 2005, 2007, 2008a, 2008b,
2009; Saporito et al., 2007a; Garraffo et al., 2012; Grant et al., 2012; Fitch et al., 2013;
Andriamaharavo et al., 2015). The quantity of unique alkaloids present in each frog was
determined using, from each of the three EI runs per frog extract, the ratio of the average
area under each alkaloid’s peak and the nicotine standard using Varian MS Workstation
v.6.9 SPI. Alkaloids that had not yet been reported in the literature (i.e., new alkaloids)
were characterized and named if they were present in three or more frogs in quantities
greater than 5 µg total.

Statistical Analysis
Since alkaloid composition is a collective measure of the number, type, and quantity of
alkaloids within individual frog skins, multidimensional scaling (MDS) was used to
visualize differences in alkaloid composition among populations. Analysis of similarity
(ANOSIM) was used to detect statistical differences in alkaloid composition among these
populations. Multivariate analyses were based on Bray-Curtis similarity matrices and
performed using PRIMER-E version 5.
A nested one-way analysis of variance (ANOVA) was used to examine variation
of growth inhibition within individual frog alkaloid treatments in both OD and CFU
assays for each microbe. In all following analyses, averages of the subsamples were used
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for each sample within each treatment. A two-tailed, unpaired, independent samples t-test
was used to determine the presence of a dose-response relationship between 2.4 and 4.8
µL doses in both OD and CFU assays for each microbe. The effects of alkaloids on
microbial growth were assessed using one-way ANOVA; final optical densities (growth
inhibition) and CFU/mL after treatment (remaining viable cells) of frog alkaloid and
methanol treatments in the 4.8 µL treatment were compared among populations and for
each pathogen. Multiple comparisons (Tukey’s HSD) were used to identify differences in
microbial growth inhibition of frog alkaloids from each population compared to methanol
treatments. To determine the effects of frog population and sex on growth inhibition,
two-way ANOVA was conducted for each assay with microbe. Linear regression
analyses were performed to assess relationships between alkaloid composition (diversity
and quantity) and growth inhibition (OD and CFU assays) for each microbe, and to test
the relationship between OD and CFU assays for each microbe. All parametric statistical
analyses were performed using SPSS version 14.0 and GraphPad Prism version 6.05.

RESULTS
Alkaloid Analysis
GC-MS analysis of 70 Oophaga pumilio from five Costa Rican populations (Fig. 1)
resulted in the identification of 353 unique alkaloids (including isomers) represented by
19 different structural classes (see Table 1 for the most common alkaloids identified in
each population and Table 2 for all identified alkaloids). The majority of these alkaloids
are derived from mites and ants. In total, 27 new alkaloids in 7 different structural classes
were identified (Table 3). Alkaloid composition of O. pumilio differed significantly
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among the five populations (Global R = 0.91; p = 0.001; Fig. 2a), but not between sexes
(Global R = -0.03; p = 0.966). Frogs from Finca los Nacientes contained the largest
number and greatest quantity of alkaloids, while frogs from Gandoca contained the
lowest number of alkaloids and contained similarly low quantities of alkaloids as frogs
from La Selva (see Table 4 for details on alkaloid composition by population and sex). In
general, frogs from Tortuguero and Finca los Nacientes contained about three times as
much alkaloid (in terms of quantity, µg per frog skin) as frogs from La Selva, Río
Palmas, and Gandoca (Fig. 2b).
Alkaloid quantity and diversity are also strongly correlated (F1,68 = 49.47, p <
0.0001; R2 = 0.421; Fig. 3), although the relationship appears to be exponential rather
than linear. In general, frogs containing higher quantities of alkaloids also possessed
more diverse alkaloid cocktails, but fewer new types of alkaloids were represented with
increasing alkaloid quantities.

Dose-Response Relationship between 2.4 µL and 4.8 µL Treatments
Exposure of both A. hydrophila and K. pneumoniae to increased doses of alkaloid
treatments indicates that there is a clear dose-response relationship between treatments
and microbial growth inhibition. With both A. hydrophila and K. pneumoniae,
respectively, 4.8 µL treatments resulted in consistently lower final optical density
readings (t138 = 13.19, p < 0.0001; t138 = 10.15, p < 0.0001) and reduced viable cell counts
(t138 = 8.47, p < 0.0001; t138 = 6.65, p < 0.0001) in comparison to 2.4 µL treatments. In
accordance with the dose-response relationship, differences in microbial growth
inhibition between control and alkaloid treatments were more evident in 4.8 µL
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treatments; therefore, the results for all following assays and comparisons are reported for
4.8 µL treatments only (Figs. 4 – 8).

Aeromonas hydrophila Optical Density Assays
Mean optical density of A. hydrophila treated with alkaloid cocktails from the five
locations of O. pumilio differed significantly among the five populations of O. pumilio
and methanol controls (F5,78 = 13.04; p < 0.0005; Fig. 4a); however, mean optical density
of A. hydrophila treated with alkaloids from individual frogs did not differ within
samples (F18,312 = 1.09; p = 0.3600). The mean optical density of A. hydrophila treated
with alkaloids from Tortuguero, La Selva, and Finca los Nacientes frogs was significantly
less than the methanol control, and the mean optical density of A. hydrophila treated with
alkaloids from Río Palmas and Gandoca frogs was not significantly less than the
methanol control. There was no interaction between the effects of frog population and sex
for optical density assays with A. hydrophila (F4,60 = 0.92, p = 0.4590).

Aeromonas hydrophila Colony-Forming Unit Assays
Mean viable cell density of A. hydrophila treated with alkaloid cocktails differed
significantly among the five populations of O. pumilio and methanol controls (F5,78 =
15.89; p < 0.0005; Fig. 4b); however, mean viable cell density of A. hydrophila treated
with alkaloids from individual frogs did not differ within samples (F12,234 = 0.90; p =
0.5450). The viable cells recovered from A. hydrophila treated with alkaloids from all
populations was significantly less than the methanol control. There was a statistically
significant interaction between frog population and sex in colony-forming unit assays
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with A. hydrophila (F4,60 = 3.79, p = 0.0080), although there was no difference in original
cell density between sexes after treatment with alkaloid cocktails from frogs (F1,60 = 0.99,
p = 0.3240); in other words, the more inhibitory sex varied among populations.

Klebsiella pneumoniae Optical Density Assays
Mean optical density of K. pneumoniae treated with alkaloid cocktails from the five
locations of O. pumilio differed significantly among the five populations of O. pumilio
and methanol controls (F5,78 = 12.67; p < 0.0005; Fig. 5a); however, mean optical density
of K. pneumoniae treated with alkaloids from individual frogs differed within samples
(F18,312 = 2.93; p < 0.0005). The mean optical density of K. pneumoniae treated with
alkaloids from Tortuguero, Finca los Nacientes, and Gandoca frogs was significantly less
than the methanol control, and the mean optical density of K. pneumoniae treated with
alkaloids from La Selva and Río Palmas frogs was not significantly less than the
methanol control. There was no interaction between the effects of frog population and sex
for optical density assays with K. pneumoniae (F4,60 = 1.99, p = 0.1070).

Klebsiella pneumoniae Colony-Forming Unit Assays
Mean viable cell density of K. pneumoniae treated with alkaloid cocktails differed
significantly among the five populations of O. pumilio and methanol controls (F5,78 =
26.41; p < 0.0005; Fig. 5b); however, mean viable cell density of K. pneumoniae treated
with alkaloids from individual frogs did not differ within samples (F12,234 = 0.52; p =
0.8990). The viable cell density of K. pneumoniae treated with alkaloids from all
populations was significantly less than the methanol control. There was a statistically
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significant interaction between frog population and sex in colony-forming unit assays
with K. pneumoniae (F4,60 = 2.81, p = 0.0330), although there was no difference in
original cell density between sexes after treatment with alkaloid cocktails from frogs
(F1,60 = 0.14, p = 0.7060); similarly to colony-forming unit assays with A. hydrophila, the
more inhibitory sex varied among populations.

Relationships between Alkaloid Composition and Growth Inhibition
Alkaloid-based growth inhibition of A. hydrophila was correlated with both alkaloid
diversity and composition of O. pumilio (Fig. 6). Alkaloid diversity was a moderate
predictor of growth inhibition by proxy of both OD (F1,68 = 48.60, p < 0.0001, R2 =
0.417; Fig. 6a) and CFU assays (F1,68 = 17.92, p < 0.0001, R2 = 0.209; Fig. 6b). Alkaloid
quantity was also a moderate predictor of growth inhibition by proxy of both OD (F1,68 =
53.46, p < 0.0001, R2 = 0.440; Fig. 6c) and CFU assays (F1,68 = 13.79, p = 0.0004, R2 =
0.169; Fig. 6d).
Alkaloid quantity, but not diversity, was a better predictor of growth inhibition of
K. pneumoniae compared to A. hydrophila (Figs. 6 and 7). Alkaloid diversity was a
moderately weak predictor of both OD (F1,68 = 19.05, p < 0.0001, R2 = 0.219; Fig. 7a)
and CFU assays (F1,68 = 34.22, p < 0.0001, R2 = 0.335; Fig. 7b). However, alkaloid
quantity was a comparatively stronger predictor of both OD (F1,68 = 63.35, p < 0.0001, R2
= 0.482; Fig. 7c) and CFU assays (F1,68 = 68.73, p < 0.0001, R2 = 0.503; Fig. 7d) for K.
pneumoniae.
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Relationship between Optical Density and Colony-Forming Unit Assays
Optical density assays and colony-forming unit assays were strongly correlated for both
A. hydrophila (F1,68 = 80.88, p < 0.0001, R2 = 0.543; Fig. 8a) and K. pneumoniae (F1,68 =
85.52, p < 0.0001, R2 = 0.557; Fig. 8b). The patterns in growth inhibition among O.
pumilio populations were identical between the two assays for both microbes (Figs. 4
and 5).

DISCUSSION
Alkaloid-based chemical defenses in poison frogs are unpalatable and/or toxic to a
variety of invertebrates and vertebrates, and function accordingly as a defense against
predators (Brodie and Tumbarello, 1978; Fritz et al., 1981; Szelistowski, 1985; Weldon
et al., 2013; Stynoski et al., 2014; Hantak et al., 2016; Hovey et al., 2016; Murray et al.,
2016). Individual alkaloids and natural alkaloid cocktails from the dendrobatid poison
frog O. pumilio have also recently been shown to inhibit the growth of microbes that are
generally considered non-pathogenic (Macfoy et al., 2005; Mina et al., 2015), suggesting
that alkaloids may provide a dual defense against both predators and microbes. The
present study supports this hypothesis and demonstrates that sequestered alkaloid
defenses from various populations of O. pumilio inhibit the growth of microbes that
infect anurans and contribute to substantial mortality in captivity and in the wild (i.e.,
pathogenic microbes); however, populations of O. pumilio also appear to vary in their
ability to inhibit these pathogens.
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Alkaloid defenses from each population of O. pumilio in the present study
effectively inhibited growth of the opportunistic, gram-negative bacteria A. hydrophila
and K. pneumoniae. Poison frogs accumulate unique suites of alkaloid defenses gradually
over the course of their lifetime as they consume alkaloid-containing arthropods
(Saporito et al., 2009). In the present study, the composition of alkaloid defenses (i.e.,
quantity and diversity) differed significantly among populations (Fig. 2; Table 1),
reflecting disparities in the type and availability of dietary arthropods at each location
(Saporito et al., 2007a, 2009, 2012). Similarly, the extent of growth inhibition of both A.
hydrophila and K. pneumoniae differed significantly among populations (Figs. 4 and 5),
most likely as a direct result of each population’s distinct alkaloid composition.
The two components that determine alkaloid composition, alkaloid quantity and
alkaloid diversity, are strongly correlated in the studied populations of O. pumilio (Fig.
3). As the quantity of alkaloids in individual frogs increased, so did the number of unique
alkaloids acquired. Likewise, alkaloid cocktails in the present study inhibited the growth
of A. hydrophila and K. pneumoniae more effectively as alkaloid quantity and alkaloid
diversity increased (Figs. 6 and 7). Accordingly, alkaloid cocktails from Finca los
Nacientes and Tortuguero frogs inhibited growth of A. hydrophila and K. pneumoniae
most effectively of all populations in both assays (Figs. 4 and 5). Finca los Nacientes
frogs were protected by alkaloid defenses that were, on average, nearly threefold greater
in quantity and 40 – 100% more diverse than those La Selva, Río Palmas, and Gandoca
frogs. Alkaloid cocktails from Tortuguero frogs were comparable in quantity to alkaloids
from Finca los Nacientes frogs, but were instead similar in diversity to alkaloids from La
Selva and Río Palmas frogs and higher in diversity than Gandoca (Table 4).
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Additionally, the predominant alkaloids present in Finca los Nacientes frog alkaloid
cocktails (comprising about half of the total quantity) included 5,8-disubstitited
indolizidines, decahydroquinolines, and histrionicotoxins, whereas the most abundant
alkaloids in Tortuguero frogs (over 60% of the total quantity) were 5,8-disubstituted
indolizidines and 5,6,8-trisubstituted indolizidines (Table 1). On the basis of these
findings, larger quantities of more diverse alkaloids provide enhanced antimicrobial
protection,

but

5,8-disubstituted

indolizidines,

5,6,8-trisubstituted

indolizidines,

decahydroquinolines, and histrionicotoxins may also be particularly inhibitory alkaloid
classes.
All populations of O. pumilio in the present study contained disproportionately
high quantities and numbers of mite-derived, branched-chain alkaloids, such as 5,8disubstituted indolizidines and 5,6,8-trisubstituted indolizidines (Tables 1 and 2), which
is typical of Costa Rican O. pumilio (Saporito et al., 2007b, 2009, 2011, 2015). However,
the alkaloid cocktails from the same populations also varied widely in inhibitory efficacy
despite sharing large proportions of these common mite-derived alkaloids (Figs. 4 and
5). The large quantities of these common alkaloids present in the more inhibitory Finca
los Nacientes and Tortuguero frogs suggest that these alkaloids may become particularly
inhibitory above a certain quantity, which could explain the comparatively reduced
inhibition by other populations that share these same alkaloids, but in lower quantities.
Alternatively, Finca los Nacientes frogs also contained distinctly high quantities of antderived decahydroquinoline and histrionicotoxin alkaloids when compared to other
populations (Table 1), which may also play an important role in Finca los Nacientes
frogs’ markedly effective inhibition. Although these findings from both mite- and ant28

derived alkaloids suggest that alkaloid quantity contributes more to microbial growth
inhibition than alkaloid diversity, the acquisition of such extreme quantities of alkaloid
defenses presumably takes years to accrue in individual frogs. Interestingly, inhibition by
La Selva frogs indicates that tremendous quantities of alkaloids, such as those present in
frogs from Finca los Nacientes and Tortuguero, are not necessary for comparable
protection.
In the present study, alkaloid diversity varied considerably, from an average of 26
unique alkaloids in Gandoca frogs to 54 unique alkaloids in Finca los Nacientes frogs,
although Tortuguero, La Selva, and Río Palmas frogs contained the average 38 unique
alkaloids per frog (Table 4). The alkaloid defenses of frogs from La Selva and Gandoca
were virtually identical in terms of average quantity, but Gandoca alkaloids were about
25% less diverse than those from La Selva, representing a unique opportunity to compare
microbial growth inhibition and alkaloid diversity with quantity held constant. In both
OD and CFU assays with A. hydrophila, Gandoca frog alkaloids were the least inhibitory
of all populations, in accord with their low diversity. In contrast, La Selva frog alkaloid
cocktails inhibited A. hydrophila virtually as well as those from Finca los Nacientes and
Tortuguero, despite having 300% lower quantities of less diverse alkaloids (Fig. 4; Table
4). This may indicate that microbial inhibition increases at a progressively reduced rate
after a certain threshold in the quantity and/or diversity of alkaloids (e.g., average
quantity and diversity of La Selva frogs), and also clearly demonstrates that increased
alkaloid diversity has the potential to considerably enhance microbial growth inhibition.
In certain cases, however, a high diversity of alkaloids may not be enough to
compensate for low quantities of alkaloids. For instance, the alkaloid cocktails of Río
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Palmas frogs were marginally more diverse than those from Tortuguero frogs (Table 4),
yet inhibited growth of K. pneumoniae the least effectively of all populations (Fig. 5).
Such substantially reduced growth inhibition of K. pneumoniae by Río Palmas frog
alkaloids was most likely a result of having the lowest quantities of alkaloids of all
populations, despite their high diversity (Table 4). In this case, the average quantity of
alkaloids in Río Palmas frogs may have been comparatively far below the hypothetical
threshold quantity after which gains in microbial inhibition diminish. Moreover, if such a
threshold quantity exists, then particular alkaloid classes are likely required rather than
any arbitrary suite of alkaloids. Coincidentally, the already low quantities of alkaloids in
Río Palmas frogs were also evenly distributed among the identified alkaloid structural
classes, which was not the case in other populations (Table 1). For example, the five
most abundant alkaloids among Río Palmas frogs were each of a different structural class
and comprised just 28% of the population’s total ~3,700 µg of alkaloids, whereas the five
most abundant alkaloids in the more inhibitory Tortuguero frog alkaloid cocktails
comprised just the two most common structural classes (5,8-disubstituted and 5,6,8trisubstituted indolizidines) and 62% of Tortuguero’s total ~14,000 µg of alkaloids
(Table 1). Accordingly, optimal growth inhibition likely requires certain quantities of
specific types of alkaloids, although even comparatively low quantities (e.g., Río Palmas)
and diversities (e.g., Gandoca) of alkaloids can inhibit the growth of these pathogens to
an extent.
Alkaloid defenses from all five populations of O. pumilio effectively inhibited
growth of the opportunistic, gram-negative bacteria A. hydrophila and K. pneumoniae,
although OD and CFU assays suggest slightly different interpretations of the results
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(Figs. 4 and 5). For example, growth inhibition approximated by OD assays indicated
that certain populations of O. pumilio, such as Río Palmas and Gandoca, did not
effectively inhibit the growth of these pathogens compared to control, which may
indicate that they are susceptible to infection. However, as evident from CFU assays,
treatment with alkaloid cocktails from these same locations significantly reduced the
amount of viable bacterial cells persisting after 24.5 hours in A. hydrophila and K.
pneumoniae cultures compared to control, which suggests that alkaloid cocktails from
Río Palmas and Gandoca are effective antimicrobial agents. These observations of
effective growth inhibition in CFU assays but not OD assays demonstrate the value of
CFU assays, and may in fact provide a more ecologically valid assessment of
antimicrobial efficacy. The discrepancies in effective growth inhibition between OD and
CFU assays for Río Palmas and Gandoca frogs are likely explained by each assay’s
measured growth variable; OD assays measured the density of both live and dead cells
suspended in solution, whereas CFU assays evaluated the quantity of viable (i.e., able to
multiply via binary fission) bacterial cells remaining after treatment with O. pumilio
alkaloid cocktails. Moreover, OD assays and CFU assays were strongly correlated (Fig.
8), and the relative patterns of growth inhibition among populations are nearly identical
between OD assays and CFU assays, wherein the most (Finca los Nacientes and/or
Tortuguero) and least inhibitory (Río Palmas and/or Gandoca) populations were
consistent between assays for each pathogen (Figs. 4 and 5).
On the basis of the relationships among O. pumilio alkaloid quantity, diversity
and microbial growth inhibition in the present study, the efficacy of alkaloid-based
microbial growth inhibition appears to increase most notably when alkaloid defenses
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comprise sufficient (e.g., >400 µg per frog skin) quantities of diverse suites of alkaloids
(e.g., >30 individual alkaloids), and when there are high quantities of certain types of
alkaloids. Consequently, although the general quantity and diversity of alkaloids in
poison frog defenses undoubtedly drive variation among populations, the presence of
specific types of alkaloids also likely plays an important role in microbial growth
inhibition. Overall, these findings support the hypothesis that alkaloid defenses from
distinct populations of O. pumilio inhibit pathogens to different degrees, which may
influence how those populations respond to emerging infectious pathogens.
Mina et al. (2015) reported similar findings, concluding that the only one of their
five studied O. pumilio populations to effectively inhibit growth of all three of the nonpathogenic microbes (B. subtilis, E. coli, and C. albicans) also had the highest quantity
and diversity of alkaloids. On the basis of findings from the present study and Mina et al.
(2015), poison frogs that sequester greater quantities and types of alkaloids (e.g., longerlived individuals that have accrued more alkaloids than younger sympatric individuals, or
populations that have access to arthropods with more and diverse alkaloid defenses) may
benefit from a more effective antimicrobial defense (Jeckel et al., 2015b). However, the
composition of alkaloid cocktails from O. pumilio in the present study suggests that
alkaloid diversity accumulates rapidly in individual frogs and levels off between 40 and
60 alkaloids, whereas alkaloid quantity increases indeterminately at a reduced rate (Fig.
3). Diversity is presumably limited as such because the assemblages of available dietary
arthropods produce a finite number of unique alkaloids. Moreover, since growth
inhibition increases with alkaloid diversity (Figs. 6 and 7; Mina et al., 2015), this
diversity limit may also entail diminishing gains in microbial inhibition as the maximum
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diversity is approached. Conversely, the quantity of alkaloid defenses in individual O.
pumilio is most likely limited only by the number and size of granular glands in the skin
(Saporito et al., 2010b), although a maximum alkaloid volume has not yet been
described. As a result, it is feasible that alkaloid quantity could virtually accrue
indefinitely. While massive quantities of alkaloids would in all probability only increase
the antimicrobial efficacy of a frog’s alkaloid defenses, results from the present study
seem to indicate that inhibitory activity is increased at progressively reduced rates past a
certain quantity. Of course, this hypothetical threshold quantity would likely be entirely
dependent on the specific alkaloids present in skin secretions, as well as the identity of
the invading pathogen.
Individual alkaloids inhibit the growth of the bacteria B. subtilis and E. coli to
varying degrees or not at all (Macfoy et al., 2005), which indicates that alkaloid types
differ in their inhibitory activity against specific types of microbes (e.g., gram-negative or
gram-positive bacteria, or various fungi, viruses, etc.). For instance, Macfoy et al. (2005)
report that nearly all individual assayed alkaloids inhibited the growth of B. subtilis,
whereas only a piperidine alkaloid inhibited E. coli. Similarly, certain individual
pyrrolidine, piperidine, decahydroquinoline, and pumiliotoxin alkaloids effectively
inhibited growth of the fungus C. albicans (Macfoy et al., 2005). In contrast, Mina et al.
(2015) reported that C. albicans was inhibited only by Isla Solarte (Panama) frog alkaloid
cocktails containing primarily decahydroquinolines and pumiliotoxin alkaloids, although
alkaloid cocktails from Puerto Viejo (Costa Rica) frogs, consisting of large amounts of
decahydroquinolines and histrionicotoxins, also inhibited C. albicans somewhat
effectively. These findings are consistent with results from the present study in
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concluding

that

certain

alkaloid

classes

such

as

decahydroquinolines

and

histrionicotoxins, which are unbranched-chain alkaloids derived from ants (Spande et al.,
1999; Daly et al., 2005; Jones et al., 2012), may be particularly inhibitory. However,
microbial inhibition by alkaloid defenses appears to be influenced by more than just the
presence of specific alkaloid types.
Important complementary and/or synergistic relationships among sequestered
alkaloids may enhance protection from pathogens in poison frogs. For example, while the
aforementioned individual alkaloids differ in terms of which types of bacteria they can
inhibit (Macfoy et al., 2005), natural alkaloid cocktails from O. pumilio that contain a
diversity of alkaloids consistently inhibit the same bacteria (Mina et al., 2015). In
synthesized amphibian chemical defenses, such as antimicrobial peptides, a combination
of various peptides is more effective than the individual peptides at inhibiting pathogenic
microbes, including A. hydrophila (Rollins-Smith et al., 2002b; Rollins-Smith, 2005;
Rosenfeld et al., 2006; Conlon, 2011a). Additionally, more diverse suites of peptides
have been proposed to provide protection from a wider range of pathogens by enhancing
other peptides’ inhibitory activity (i.e., synergy), or by different peptides or classes
targeting different classes of microbes (i.e., complementary) (Nicolas and Mor, 1995;
Simmaco et al., 1998b; Zasloff, 2002; Tennessen et al., 2009). Based on previous
alkaloid-based microbial inhibition research and relationships between inhibition and
alkaloid composition from the present study, similar synergistic and/or complementary
effects may occur in sequestered alkaloid defenses, where comparatively diverse alkaloid
cocktails provide enhanced protection from a wider range of pathogens.
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Relatively little is known about the antimicrobial function of sequestered
alkaloids in the skin of dendrobatids. However, synthesized antimicrobial peptide
defenses are common among amphibians, and are considered effective as an innate
defense against pathogens and in preventing wound infection (Zasloff, 1987; Nicolas and
Mor, 1995; Simmaco et al., 1998b). Frog species with greater quantities of diverse suites
of antimicrobial peptides appear to be better protected (Zasloff, 2002; Tennessen et al.,
2009), and the expression of antimicrobial peptides defenses increases following
infection (Miele et al., 1998; Pask et al., 2012). Although antimicrobial peptides in Rana
pipiens have been shown to degrade fairly quickly (i.e., active for 15 minutes to 2 hours),
this is hypothesized to represent a compromise between limiting pathogen infection
intensity in critical situations and harm to residential, potentially beneficial microbiota
(Woodhams et al., 2007b; Conlon, 2011b; Pask et al., 2013). The duration that secreted
alkaloids remain on the skin is not yet known in dendrobatids, although alkaloids are
unlikely to degrade similarly to antimicrobial peptides and would likely represent a
comparatively constant first line of defense against microbial pathogens encountered in
the environment. While most amphibian antimicrobial peptides form pores in the plasma
membrane of gram-negative bacteria to disrupt cellular membranes and subsequently
disintegrate the cells (Yang et al., 2001; Brogden, 2005; Diamond et al., 2009; Chen et
al., 2012), little is known about the antimicrobial capacity and mechanism of action of
poison frog alkaloids.
Lipophilic alkaloids in poison frogs vary in their neuromuscular modes of action
by structural class, but in general block or prevent the inactivation of sodium channels
and nicotinic acetylcholine receptors (Daly and Spande, 1986; Daly et al., 1999;
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reviewed in Santos et al., 2016). The various classes of alkaloids may have antimicrobial
mechanisms of action that correspond to those observed in muscles and neurons, or they
may act in a yet unknown way to disrupt normal bacterial processes. Moreover, classes of
alkaloids that differ in their mechanism of action most likely vary in their antimicrobial
efficacy and the type of microbes they are effective against (e.g., gram-positive or gramnegative bacteria, fungi, or viruses, which differ widely in structure). Lipophilic alkaloids
are not amphipathic like antimicrobial peptides and therefore cannot induce pore
formation to disrupt microbial membranes. However, much like lipid-binding properties
enhances cytotoxicity in antimicrobial peptides (Mahalka and Kinnunen, 2009), the
lipophilic properties of sequestered alkaloids may facilitate binding to microbial cell
membranes and/or uptake into the cells. Sequestered alkaloids may therefore be able to
depolarize bacterial membranes by binding to various ion channels (Saimi et al., 1998),
which could result in solute influx or efflux that disrupts microbial cells, or they could
possibly have intracellular targets that influence their antimicrobial activity. For example,
many alkaloids act as antimicrobials through the inhibition of efflux pumps (i.e., active
transport pumps) (Markham et al., 1999; Maurya et al., 2013; reviewed in Cushnie et al.,
2014), and certain indolizidine alkaloids have been proposed to inhibit nucleic acid
synthesis (Rao and Vekatachalam, 2000). Although very little is known about the
antimicrobial activity of poison frog alkaloids, these types of microbial interactions may
allow frog alkaloids to kill bacteria directly (i.e., bactericidal action) and/or inhibit
bacterial reproduction (i.e., bacteriostatic action).
Alkaloid defenses in poison frogs may provide dual predator and pathogen
protection. For example, prospective predators that sample and ultimately reject poison
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frogs as a prey item (Brodie and Tumbarello, 1978; Fritz et al., 1981; Szelistowski, 1985;
Gray et al., 2010; Stynoski et al., 2014; Hantak et al., 2016; Hovey et al., 2016; Murray
et al., 2016) stimulate the secretion of defensive alkaloids onto the skin, and may inflict
wounds that could be potentially fatal if infected. In this case, poison frog alkaloid
secretions could potentially reduce wound infection and inhibit the growth of nonresidential microbes including pathogens. However, it should be noted that a resident
microbiota community almost certainly persists in the presence of alkaloid defenses
(Culp et al., 2007; Lauer et al., 2007; Walke et al., 2015). Additionally, it is feasible that
incipient infections in poison frogs may elicit a stress response that stimulates smooth
muscle around granular glands, thereby inducing the secretion of additional alkaloids
onto the skin to reduce the viable infection load. For instance, Rana esculenta and
Bombina orientalis induce and/or upregulate synthesized antimicrobial peptide defenses
after exposure to microbes, including A. hydrophila (Miele et al., 1998; Simmaco et al.,
1998a; Mangoni et al., 2001). Sequestration of arthropod-derived alkaloids by poison
frogs may therefore be analogous in some ways to synthesized peptide defenses (Zasloff,
1987; Pask et al., 2013) and play an important role in protection from infectious
pathogens, especially when the innate immune system is compromised or the frog is
wounded.
Amphibians are inhabited by communities of microbes (e.g., gut-associated
microbes and skin-associated microbes), some of which are symbiotic and complement
their innate immune system by defending the host from infectious pathogens (Culp et al.,
2007; Lauer et al., 2007, 2008; Woodhams et al., 2007c; Myers et al., 2012; Park et al.,
2014; Becker et al., 2015). Conversely, certain gram-negative gut- or skin-resident
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microbes that are frequently isolated from wild and captive frogs, such as A. hydrophila
and K. pneumoniae (Hunsaker and Potter, 1960; Lee and Franz, 1973; Hird et al., 1981,
1983; Bradford, 1991; Barra et al., 1998), can cause fatal systemic infections (i.e., “redleg syndrome”; Rigney et al., 1978; Taylor et al., 2001) in immunocompromised
amphibians (Carr et al., 1976; Hubbard, 1981; Pearson, 1998). Of these microbes, A.
hydrophila in particular has been linked to wild and captive population amphibian
declines (Nyman, 1986; Pearson et al., 2000; Huys et al., 2003; Miller et al., 2008; Hill et
al., 2010). The resistance and resulting virulence of A. hydrophila appears to be due to its
production of extracellular proteases that break down amphibian antimicrobial peptides,
rendering these synthesized chemical defenses largely ineffective (Rollins-Smith et al.,
2002a; Schadich and Cole, 2009). Metabolites of Phyllomedusa distincta skin microbiota
also effectively inhibited growth of E. coli and other microbes in an optical density-based
growth inhibition assay, whereas A. hydrophila was most resistant to growth inhibition.
Additionally, K. pneumoniae was not inhibited by the same metabolites, although in a
separate streak assay (Brito de Assis et al., 2016). In the present study, alkaloid cocktails
from all populations of O. pumilio clearly inhibited the resistant pathogen A. hydrophila
and the relatively resistant, occasionally more pathogenic, K. pneumoniae. The
conclusion that poison frog alkaloids can reliably inhibit A. hydrophila may indicate that
the extracellular proteases produced by the pathogen are inactive against sequestered
alkaloids, especially given that those proteolytic compounds confer A. hydrophila
resistance to antimicrobial peptides (Rollins-Smith et al., 2002a; Tennessen et al., 2009;
Brito de Assis et al., 2016). This is consistent with the hypothesis that A. hydrophila
proteases coevolved specifically with widespread amphibian chemical defenses, such as
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synthesized peptides or microsymbiont-derived metabolites, as an adaptation to survive
on amphibian skin (Schadich and Cole, 2009). Alternatively, the mechanism of action of
poison frog alkaloids may simply be more effective against A. hydrophila and K.
pneumoniae than that of the antimicrobial peptides and metabolites studied so far.
However, the same antimicrobial peptides that do not inhibit A. hydrophila can
effectively inhibit the pathogen most closely associated with global amphibian population
declines and biodiversity loss, Batrachochytrium dendrobatidis (Berger et al., 1998;
Rollins-Smith et al., 2002b). The inhibitory activity of sequestered alkaloid defenses
against Bd is not yet known. Thus, although findings from the present study demonstrate
that poison frog alkaloids can function as an effective defense against virulent pathogens,
the inhibitory activity of alkaloid defenses against other highly-relevant pathogens
remains to be determined.
The chytrid fungus Bd is the primary pathogen implicated in disease-related
amphibian declines (Blaustein et al., 2012). Nonetheless, various other pathogens
including ranaviruses, water molds, and mycobacteria frequently co-occur with chytrid
and one another (Miller et al., 2008; Hill et al., 2010; Prada-Salcedo et al., 2011;
Hoverman et al., 2012; Souza et al., 2012; Whitfield et al., 2013; Warne et al., 2016),
and likely contribute to disease dynamics and amphibian population declines. Numerous
poison frog species are endemic to habitats in which these pathogens are prevalent and
amphibian population declines have been observed (Hunter et al., 2010a; Catenazzi et al.,
2011; Whitfield et al., 2012; Agostini et al., 2015; Rodríguez-Brenes et al., 2016).
Moreover, although the Malagasy lineage of Mantella poison frogs is endemic to
localized habitats that have not yet experienced pathogen-related amphibian declines, low
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infection loads of Bd and ranavirus infection have recently been detected in sympatric
native amphibians, and these habitats are climatically suitable for the establishment and
potential outbreak of the aforementioned pathogens (Kolby, 2014; Bletz et al., 2015;
Kolby and Skerratt, 2015; Kolby et al., 2015). The presence of Bd and other pathogens is
also unlikely to be eliminated from the environment, so effective treatment strategies for
a range of pathogens are imperative in order to facilitate the persistence of natural frog
populations in situ, and mitigate amphibian biodiversity decline. Treatment with
antimicrobial peptides appears to be an effective treatment for clearing infection in
diseased amphibians, particularly for those lacking antimicrobial peptides (Woodhams et
al., 2012). Conversely, although these treatments are beneficial for treating infected
amphibians, they do not provide an effective long-term survival solution. Probiotic
bioaugmentation, wherein amphibians are supplemented with cutaneous bacteria that
produce antimicrobial metabolites and promote survival in infected frogs (Lam et al.,
2010; Becker et al., 2011; Flechas et al., 2012; Woodhams et al., 2014), has been
proposed as a feasible in situ and ex situ conservation approach to mitigate disease
prevalence and mortality in at-risk amphibian species and communities (Muletz et al.,
2012; Bletz et al., 2013; Woodhams et al., 2016). However, poison frogs, which
effectively lack synthesized peptide defenses (Daly et al., 1984, 1987; Erspamer et al.,
1986; Prates et al., 2012) and have not been examined for bacterial communities, may
resist or be less receptive to probiotic bioaugmentation as a consequence of the toxic
sequestered alkaloids in their skin secretions.
A prospective alternative for endangered or at-risk poison frogs may be dietary
supplementation with alkaloids, which would facilitate the accumulation of sequestered
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defenses. Based on results from this study, alkaloid supplementation could potentially
inhibit the growth of pathogens in captive poison frogs and upon reintroduction to their
natural habitat. Especially considering that the amphibian immune system is significantly
impaired during metamorphosis (Rollins-Smith, 1998), such an approach would be
particularly important for poison frogs raised in captivity (e.g., certain ex situ
conservation programs, or zoo collections), which would not have had access to alkaloidcontaining dietary arthropods that occur in their natural habitat. In some amphibians,
synthesized peptides and bacterial symbionts provide protection from disease in
embryonic, larval, and juvenile life stages (Banning et al., 2008; Walke et al., 2011; Pask
et al., 2013; Holden et al., 2015). However, comparable defenses have not been identified
in poison frogs, which underscores the importance of their sequestered alkaloids,
particularly in earlier life stages. For instance, maternal provisioning of alkaloids via
nutritive eggs is the sole source of alkaloid defenses for dendrobatid poison frog tadpoles
of the genus Oophaga, wherein these provisioned alkaloids provide critical early
protection from predators (Stynoski et al., 2014). On the basis of the present study,
provisioned alkaloids may also reduce susceptibility to microbial pathogens through the
critical transition to metamorphosis. Although maternal provisioning of alkaloids appears
to be unique to members of the genus Oophaga poison frogs, it is conceivable that
analogous alkaloid supplementation of other poison frogs in the early stages of life would
enhance resistance to infectious pathogens, which is critical for endangered poison frogs.
A variety of poison frogs are represented in conservation programs (McFadden et
al., 2013; Edmonds et al., 2015), but little is known about how sequestered alkaloids
protect them from infectious pathogens, or how alkaloids may be utilized to their
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advantage. For example, certain Australian Pseudophryne frogs were extirpated from the
wild by Bd and are fortunately represented in ex situ conservation programs (McFadden
et al., 2013; Brannelly et al., 2015a, 2015b). Pseudophrynaminol, a synthesized alkaloid
unique to this genus (Daly et al., 2005), does not inhibit the growth of B. subtilis, E. coli,
or C. albicans (Macfoy et al., 2005) or elicit toxicosis in the fire ant S. invicta (Weldon et
al., 2013), suggesting that its synthesized alkaloid defenses may not be particularly useful
in inhibiting growth of pathogenic microbes and subsequently in facilitating successful
reintroductions. However, since Pseudophryne spp. are also capable of sequestering
pumiliotoxin alkaloids (Daly and Garraffo, 1990), future studies could assess whether
sequestered alkaloids, or synthesized pseudophrynamines, are effective at inhibiting
pathogens such as Bd, which may inform beneficial captive management strategies.
Aside from the critically endangered Pseudophryne frogs, other species and populations
of poison frogs are surely susceptible to pathogens. Future research could therefore
include assessments of susceptibility from a wide range of lineages and populations of
poison frogs. Electrical stimulation of granular glands to secrete alkaloids may be used as
a minimally invasive field method of evaluating the composition and antimicrobial
capacity of poison frog alkaloid defenses (Grant and Land, 2002; Daly et al., 2008a;
Clark, 2010; Hantak et al., 2013). Overall, assessments of the antimicrobial efficacy of
natural poison frog alkaloid defenses would undoubtedly be useful in determining
prioritization strategies for conservation management of poison frogs now and in the
future, when interactions between threats like continued habitat loss, climate change, and
spreading infectious diseases may accelerate amphibian declines.
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Research on synthesized amphibian chemical defenses in recent decades has
developed our understanding of host-pathogen interactions extensively, but similar
research on comparatively uncommon sequestered defenses such as alkaloids has just
begun. Continued research is needed to examine relationships between sequestered
poison frog alkaloid defenses and pathogens implicated in amphibian declines in order to
determine which aspects of alkaloid defenses contribute most to growth inhibition, as
well as to assess the practicality and efficacy of alkaloid provisioning for poison frogs of
various life stages. Relevant pathogens to prioritize in such studies include Bd,
ranaviruses, and water molds (Saprolegnia spp.), which are frequently observed in
disease-induced mortality of amphibians in the field (Pessier, 2002; Prada-Salcedo et al.,
2011) and have been involved in peptide research (Rollins-Smith, 2009). Thus far, the
majority of microbial inhibition research with amphibian chemical defenses has utilized
OD assays to assess growth inhibition. Accordingly, comparisons between OD and CFU
assay results in the present study may also inform experimental design decisions in future
research. For instance, since certain populations of O. pumilio inhibited growth compared
to control treatments in CFU assays but not in the preceding OD assays (Figs. 4 and 5),
assessments of the antimicrobial efficacy of amphibian chemical defenses may require
CFU assays following OD assays to accurately determine whether the compounds
inhibited growth compared to control treatments. Conversely, since the relative patterns
of growth inhibition among populations are nearly identical between OD assays and CFU
assays for these pathogens (Figs. 4 and 5; Fig. 8), OD assays alone may be sufficient to
estimate and compare the antimicrobial capacity of chemical defenses of different types
or from various amphibian populations or taxa.
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In the present study, results from these microbial growth inhibition assays serve
as a step towards understanding whether poison frog alkaloid defenses may have evolved
as a means of protection against pathogenic microbes. Much like variation in alkaloid
defenses is hypothesized to play a role in defense against predators (Saporito et al., 2006,
2007a; Murray et al., 2016), these findings suggest that the natural variation in poison
frog alkaloid defenses influences protection from pathogenic microbes. As a result of
comparable variation in dietary arthropods (Clark et al., 2006; Bonansea and Vaira, 2007;
Daly et al., 2008a; Quiroga et al., 2011; Andriamaharavo et al., 2015), similar trends in
microbial inhibition would likely be observed in other poison frog lineages, some of
which are endangered due to threats such as continued habitat loss and spreading disease
and would likely benefit from conservation management in captive breeding programs.
Accordingly, findings from the present study may also be useful in improving
conservation programs and strategies for poison frogs.
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Table 1. The five most abundant alkaloids (in terms of relative quantity) identified in the
skin of Oophaga pumilio from each population.
Population

Arthropod source of alkaloids
Mites
Structural
Alkaloid
class

Ants
Structural
Alkaloid
class

Percent of population's
total alkaloids

62%

Tortuguero

5,6,8-I
5,8-I

251T, 223A
247E, 205A, 207A

La Selva

5,8-I
Unclass

207A, 195I
311A, 209G

Lehm

275A

48%

Finca los Nacientes

5,8-I

195I, 207A

DHQ
HTX

269AB, 269A
285C

46%

Río Palmas

Izi
5,6,8-I
Tri

209L
223A
253S

3,5-P
Pyr

251K
197B

28%

Gandoca

5,8-I
5,6,8-I

251N
249C, 259C

Lehm
DHQ

275A
195A

57%

Abbreviations for alkaloid classes are as follows: 3,5-P (3,5-disubstituted pyrrolizidine); 5,6,8-I (5,6,8-trisubstituted
indolizidine); 5,8-I (5,8-disubstituted indolizidine); DHQ (decahydroquinoline); HTX (histrionicotoxin); Izi (izidine);
Lehm (lehmizidine); Pyr (pyrrolidine); Tri (tricyclic); Unclass (unclassified).
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Table 2. Alkaloids detected in Oophaga pumilio arranged by structural class.

Total

1,4-Q

3,5-I

3,5-P

4,6-Q

5,6,8-I

5,8-I

aPTX

Dehydro- DeoxyDHQ
5,8-I
hPTX

231A
233A
257D(2)
259E
279E

195B(2)
223AB(2)
223R
275C

195F
223B(3)
223H(3)
249I(2)
251K(3)
251O
265J(3)

237I
251Y
253X
265DD

195G
221P
221Q
223A(5)
223C
231B(3)
235E
237C(2)
237L(3)
249C(4)
251M(2)
251S
251T(2)
253H(4)
259C(2)
263A(4)
265L(2)
267J
267CC
275E(6)
277E(2)
279F
293C

195I(2)
203A
205A(3)
207A(4)
207Q
209I
209S
217B(3)
219F(2)
221I
223D(2)
223J(2)
223AA
231C(3)
231G
233D
235B(2)
237D(2)
239G
241F
243B
245I(3)
247E(2)
249O(2)
251N(2)
259B
261D(4)
263F(2)
265P
271A
273B(2)
273C
275F

241H
253A
267A
293K(2)
309D(2)
323B
341A

201A
193F
203E
207O
205L(2)
221D
221J
245F
265F(2)

5

4

7

4

23

33

7

7

2

HTX

Izidine

195A
211A
223F
237U
251A(2)
267L(2)
269AB(6)
269A(2)
269B(4)
271D(3)
275B(3)

283A(2)
285A(5)
285C(2)
287A(2)
287B(3)
291A

11

6

Lehm

PTX

Pyr

193J
275A(5) 211I(2)
195K
277A(3) 211J
209L(3)
225I(2)
211B(4)
239I(2)
211F
239L(2)
221N(2)
241D(4)
223I
241G(2)
225G(2)
253J(2)
239A
253U
239CC
267K(5)
247J(2)
267X(2)
267BB
269C
291B

225F
237A(2)
265D
277B
307A(4)
321A
323A(2)
325B

183B
236
197B(5) 252A
211T
225P
235F
253F
253I
267EE
277D(2)
277J
279M

207GH(4)
207R
219O
221G
221M
221W
245J
247N
249Z
253S(5)
261C(2)
261F
261H
275L

167H
195N
197K
207N
209G(2)
211D
223L
235I
235M
235S
245R
247L
247P
247Q
249N(2)
251HH
261K
261L
265K
267I
267O(2)
267Q(6)
267DD
269E(3)
269K
271E
273F
275M
281U
283I
291K
311A
323I(2)

13

8

11

14

33

2

Pip

12

Spiro Tri

1

Unclass

203

Alkaloids present in quantities greater than 0.5 µg in at least one frog are listed, except in the case of new alkaloids (see Table 3). Alkaloids that are underlined represent
tentatively new alkaloids that have not been previously described. Abbreviations for alkaloid classes are as follows: 1,4-Q (1,4-disubstituted quinolizidine); 3,5-I (3,5-disubstituted
indolizidine); 3,5-P (3,5-disubstituted pyrrolizidine); 4,6-Q (4,6-disubstituted quinolizidine); 5,6,8-I (5,6,8-trisubstituted indolizidine); 5,8-I (5,8-disubstituted indolizidine); aPTX
(allopumiliotoxin); Dehydro-5,8-I (dehydro-5,8-disubstituted indolizidine); Deoxy-hPTX (deoxy-homopumiliotoxin); DHQ (decahydroquinoline); HTX (histrionicotoxin); Lehm
(lehmizidine); Pip (piperidine); PTX (pumiliotoxin); Pyr (pyrrolidine); Spiro (spiropyrrolizidine); Tri (tricyclic); Unclass (unclassified).
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Table 3. Retention times (Rt) for newly identified alkaloids from Oophaga pumilio (see
Appendix 31 for mass spectral data). The Rt for each alkaloid is accompanied by an
approximate "corrected Rt" that corresponds to the retention times in the alkaloid library
of Daly et al. (2005). Following the methods of Garraffo et al. (2012), based on
comparisons of Rts for previously identified alkaloids in the present study with Rts from
Daly et al. (2005), alkaloids in the present study eluted approximately 0.34 seconds faster
than times listed in Daly et al. (2005).
Str. Class

Alkaloid

Rt

Corrected Rt

Unclass
Unclass
Unclass
Dehydro-5,8-I
Pyr
Unclass
Unclass
Unclass
Unclass
4,6-Q
Unclass
Unclass
4,6-Q
Izi
5,6,8-I
Unclass
Pyr
Unclass
Unclass
Tri
Unclass
Pyr
Pyr
Unclass
Unclass
Unclass
Unclass

167H
195N
197K
203E
225P
245R
247P
247Q
251HH
253X
261K
261L
265DD
267BB
267CC
267DD
267EE
269K
273F
275L
275M
277J
279M
281U
283I
291K
311A

5.67
7.53
7.37
8.98
9.70
12.04
10.77
11.69
11.61
9.70
12.94
12.96
13.30
12.65
12.80
13.49
14.40
11.38
14.88
13.92
14.01
14.28
14.33
13.88
15.56
15.75
15.22

5.33
7.19
7.03
8.64
9.36
11.70
10.43
11.35
11.27
9.36
12.60
12.62
12.96
12.31
12.46
13.15
14.06
11.04
14.54
13.58
13.67
13.94
13.99
13.54
15.22
15.41
14.88

Abbreviations for alkaloid classes are as follows: 4,6-Q (4,6-disubstituted quinolizidine); 5,6,8-I (5,6,8-trisubstituted
indolizidine); Dehydro-5,8-I (dehydro-5,8-disubstituted indolizidine); Izi (izidine); Pyr (pyrrolidine); Tri (tricyclic);
Unclass (unclassified).
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Table 4. Diversity (alkaloids per frog skin) and quantity (µg per frog skin) of alkaloid
defenses from each population of Oophaga pumilio.
Average Average ♀ Average ♂
Total
diversity diversity diversity diversity

Total ♀
diversity

Total ♂
diversity

Tortuguero
La Selva
Finca los Nacientes
Río Palmas
Gandoca

37
33
54
39
26

39
36
55
42
21

36
30
53
36
31

521
458
758
548
364

272
250
441
334
147

249
208
317
214
217

All populations

38

39

37

2649

1444

1205

Total
quantity

Total ♀
quantity

Total ♂
quantity

Average Average ♀ Average ♂
quantity
quantity
quantity
Tortuguero
La Selva
Finca los Nacientes
Río Palmas
Gandoca

986
344
1181
264
344

1224
462
1219
295
280

748
225
1130
223
524

13807
4811
16528
3697
4812

8567
3233
9750
2357
1148

5239
1578
6778
1340
3665

All populations

624

677

564

43656

25056

18600
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Figure 1. Map of five Oophaga pumilio collection sites in Costa Rica.
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a

b

Figure 2. MDS plots [(a) original MDS plot; (b) scaled to quantity)] of alkaloid
composition for five populations of Oophaga pumilio. Each point represents an
individual frog (70 frogs total, 14 per population). The distance between symbols
represents differences in alkaloid composition (number, type, and quantity of alkaloids
per frog skin; in (b) the diameter of each point is scaled to quantity of alkaloids per frog,
and La Selva frogs are encircled by a dotted line to distinguish them from nearby points).
Points that are closer together represent frogs that have more similar alkaloid profiles,
whereas points that are further apart represent frogs with less similar alkaloid profiles.
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● Tortuguero

■ La Selva

▲

Finca los Nacientes

♦ Rίo Palmas

▼

Gandoca

Figure 3. Relationship between alkaloid quantity (µg per frog skin) and diversity
(alkaloids per frog skin) in Oophaga pumilio from five populations throughout Costa
Rica.
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Figure 4. Mean final optical densities (OD620) (a) and viable cell densities (CFU/mL) (b)
of Aeromonas hydrophila after treatment with alkaloid cocktails extracted from Oophaga
pumilio. The dotted line represents the mean OD620 and CFU/mL for the methanol
control, error bars represent ± 1 standard error of the mean, and treatment means that are
significantly different from each other are indicated by different letters (Tukey’s HSD, p
< 0.05).
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Figure 5. Mean final optical densities (OD620) (a) and viable cell densities (CFU/mL) (b)
of Klebsiella pneumoniae after treatment with alkaloid cocktails extracted from Oophaga
pumilio. The dotted line represents the mean OD620 and CFU/mL for the methanol
control, error bars represent ± 1 standard error of the mean, and treatment means that are
significantly different from each other are indicated by different letters (Tukey’s HSD, p
< 0.05).
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● Tortuguero

■ La Selva

▲

Finca los Nacientes

♦ Rίo Palmas

▼

Gandoca

Figure 6. Relationship between alkaloid profiles of individual Oophaga pumilio and
corresponding growth inhibition of Aeromonas hydrophila [(a) alkaloid diversity
(alkaloids per frog skin) and optical density assay; (b) alkaloid diversity (alkaloids per
frog skin) and colony-forming unit assay; (c) alkaloid quantity (µg per frog skin) and
optical density assay; (d) alkaloid quantity (µg per frog skin) and colony-forming unit
assay].
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● Tortuguero

■ La Selva

▲

Finca los Nacientes

♦ Rίo Palmas

▼

Gandoca

Figure 7. Relationship between alkaloid profiles of individual Oophaga pumilio and
corresponding growth inhibition of Klebsiella pneumoniae [(a) alkaloid diversity
(alkaloids per frog skin) and optical density assay; (b) alkaloid diversity (alkaloids per
frog skin) and colony-forming unit assay; (c) alkaloid quantity (µg per frog skin) and
optical density assay; (d) alkaloid quantity (µg per frog skin) and colony-forming unit
assay].
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● Tortuguero

■ La Selva

▲

Finca los Nacientes

♦ Rίo Palmas

▼

Gandoca

Figure 8. Relationship between optical density and colony-forming unit assays for (a)
Aeromonas hydrophila and (b) Klebsiella pneumoniae treated with alkaloids extracted
from Oophaga pumilio.
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APPENDIX
Cryopreservation of Microbes
Upon receipt of Aeromonas hydrophila (ATCC® 35654™) and Klebsiella pneumoniae
subsp. pneumoniae (ATCC® 13883™), 30 mL TSB stock cultures were grown in 50 mL
conical tubes and incubated for 24 hours at 30°C (A. hydrophila) or 37°C (K.
pneumoniae) in a shaking incubator set to 100 rpm. Twelve 1 mL frozen stock cultures
were created from the initial 30 mL cultures by adding 900 µL of the culture to 100 µL
sterile 80% glycerol in each of twelve labeled cryovials. Frozen stock cultures were
stored at -80°C until use in assays.

Pilot Experiments
A variety of preliminary pilot experiments were conducted to determine optimal dilutions
and corresponding growth curves of microbial cultures for use in microbial growth
inhibition assays, and to examine the effect that various volumes of the vehicle control
(methanol) had on the growth of each microbe.

Effect of Methanol on Growth of Various Dilutions of Bacterial Cultures
Aeromonas hydrophila OD Pilot Assays
A 30 mL culture of A. hydrophila was grown from an isolated colony on a streak plate
and incubated at 30°C with agitation at 100 rpm for 18 hours. Three 10 mL dilutions (1:5,
1:10, and 1:50) were created from this 30 mL culture. For the 1:5 dilution, 2 mL of A.
hydrophila culture was added to 8 mL TSB. For the 1:10 dilution, 1 mL A. hydrophila
culture was added to 9 mL broth. For the 1:50 dilution, 0.2 mL of A. hydrophila culture
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was added to 9.8 mL broth. All dilutions were vortexed for five seconds and then poured
into individual plastic troughs immediately prior to transferring aliquots to 96-well
microplates. Equal 200 µL volumes (subcultures) of each dilution were immediately
plated in a 96-well microplate such that each dilution occupied three columns of eight
replicate wells each (total nine columns used per pilot assay). The eight replicate wells in
the first of three columns of each of the 1:5, 1:10, and 1:50 dilutions acted as the negative
control and were not inoculated, which created a typical growth curve for A. hydrophila
alone at each dilution. The eight wells in the second columns of each dilution were
inoculated with 5 µL of methanol as a proxy for estimating the effect of 4.8 µL of
methanol on growth of A. hydrophila. The eight wells in the third columns of each
dilution were inoculated with 10 µL of methanol as a proxy for estimating the effect of
9.6 µL of methanol on growth of A. hydrophila. After preparation, the microplate was
placed in the microplate reader and OD620 was measured over the course of a 24.5-hour
program that recorded OD620 at 15-minute intervals and shook the plate at medium speed
for five seconds prior to each measurement. All eight OD620 measurements for replicate
wells for each of the nine treatments were treated as subsamples and were averaged to
visualize growth curves.
This pilot assay was conducted twice to verify the repeatability of the results. In
both assays, identical trends in A. hydrophila growth were observed (Appendix 1). The
1:5 and 1:10 dilutions were clearly in mid-log growth phase at the start of the assay and
had nearly overlapping growth curves when inoculated with no methanol and 5 µL
methanol, although the 1:5 dilution had a slightly higher OD620 throughout the 24.5-hour
growth period. The 1:50 dilution entered log growth phase after a slight (< 1 hour) delay
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compared to the 1:5 and 1:10 dilutions, and had a reduced OD620 after 24.5 hours in
comparison to the 1:5 and 1:50 dilutions. When inoculated with 10 µL methanol, all
dilutions went through a 10 – 12 hour lag phase before entering log growth phase, and
grew to a maximum OD620 nearly half that of all other growth curves; this suggested that
10 µL methanol was not a feasible vehicle control volume to use in OD assays.
Therefore, a pilot experiment comparing 5 µL methanol and 7.5 µL methanol was
conducted.
The above procedure was carried out identically for this third pilot assay, but 7.5
µL methanol was used in place of 10 µL methanol. Growth curves for the 1:5, 1:10, and
1:50 dilutions of A. hydrophila were identical to the previous pilot assays in treatments
when not inoculated with methanol and when inoculated with 5 µL, but the addition of
7.5 µL methanol still delayed log growth by 3 – 5 hours and reduced the final OD620 by
nearly half (Appendix 2). Therefore, 7.5 µL was determined to be an unsuitable vehicle
control volume to use in OD assays, and a pilot assay examining the effect of 2.4 µL
methanol and 4.8 methanol on growth at each of the three previous dilutions was
conducted.
Using the above procedures, growth curves of A. hydrophila at 1:5, 1:10, and 1:50
dilutions were identical to those in previous pilots in the absence of methanol and when
inoculated with 4.8 µL methanol (Appendix 3). Moreover, growth curves of A.
hydrophila inoculated with 2.4 µL methanol were very similar to growth curves of A.
hydrophila that had not been inoculated with methanol, which indicated that this volume
is ideal for a vehicle control in growth inhibition assays. Based on these growth curves,
the 1:10 dilution was determined to be most suitable for growth inhibition assays since it
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started at an intermediate OD620 compared to 1:5 and 1:50 dilutions and appeared to start
at the very beginning of log growth phase in each assay, thereby providing the most
appropriate growth curve with which to assess growth inhibition due to alkaloids. Since
growth curves of A. hydrophila inoculated with 4.8 µL methanol were somewhat
inhibited compared to A. hydrophila not inoculated with methanol, a pilot assay was
conducted to determine whether or not adding methanol in the mid-log phase (after a 1.5
hour delay) would change rates of growth at the mid-log phase in the 1:10 dilution of A.
hydrophila.
In this pilot assay, A. hydrophila was cultured and diluted following the same
procedure as previous pilots, but the 1:10 dilution of A. hydrophila was examined under
five conditions in triplicate: no methanol, 2.4 µL methanol added prior to measurements,
4.8 µL methanol added prior to measurements, 2.4 µL methanol added 1.5 hours after
starting the assay, and 4.8 µL methanol added 1.5 hours after starting the assay.
Measurements were recorded for a total of 4.25 hours, which is when log phase growth
tended to stop in previous pilot assays. The results suggest that adding methanol after a
1.5-hour delay caused growth after 4.25 hours to be nearer in OD620 to growth in the
absence of methanol in comparison to methanol added at the beginning of the assay
(Appendix 4). This is supported by the observation that, at 1.5 hours, growth curves of A.
hydrophila with methanol added initially were lower in OD620 than A. hydrophila in the
other three treatments that did not contain methanol at that point. Until the addition of
methanol 1.5 hours into the assay, the other three treatments overlapped almost exactly.
Interestingly, the addition of 2.4 µL methanol before assays seemed to cause an increase
in growth of A. hydrophila after 2.4 hours.
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In order to determine whether or not a similar effect would occur if natural frog
alkaloids were added after a 1.5-hour delay, this pilot was replicated with the addition of
two more treatments: 4.8 µL of alkaloids in methanol from frog GAN-2F (female frog
collected from Gandoca) after a 1.5-hour delay and 4.8 µL of alkaloids in methanol from
frog GAN-3F (female frog from Gandoca) after a 1.5-hour delay. These two frogs were
selected for this pilot because they had the widest variation in alkaloid quantity of frogs
available at that point in the experiment (414 µg vs. 45 µg per frog skin). Following the
procedure from the previous pilot assay, nearly identical results were obtained with the
addition of the two 4.8 µL alkaloid treatments (Appendix 5). Growth of A. hydrophila
that was inoculated with methanol after a 1.5-hour delay was slightly closer in OD620 to
that of A. hydrophila in the absence of methanol, and 2.4 µL methanol added prior to the
assay caused a slight increase in OD620 after 4.25 hours. Delayed addition of 4.8 µL
alkaloids in methanol from GAN-2F, which contained a significantly higher quantity of
alkaloids than GAN-3F, caused OD620 to be lower after 4.25 hours in comparison to
delayed addition of 4.8 µL methanol alone. Delayed addition of 4.8 µL alkaloids in
methanol from GAN-3F resulted in OD620 similar to delayed addition of methanol alone,
though still lower than growth of A. hydrophila in the absence of methanol. These results
suggest that alkaloids from frogs with a relatively high quantity of alkaloids may inhibit
growth, while frogs with relatively small quantities of alkaloids may not show inhibition
compared to the vehicle control. Inoculation of methanol and alkaloids prior to beginning
assays was ultimately selected as the most appropriate procedure since the delayed
addition of treatments required removing the microplate from the microplate reader and a

90

45-minute period of inoculating subsamples with methanol and alkaloids during which
the subsamples would grow exponentially.
Lastly, to verify that the addition of alkaloids inhibited growth after 24.5 hours
compared to methanol alone, a pilot assay was conducted using triplicate subsamples of
1:10 diluted A. hydrophila in seven treatments: absence of methanol, 2.4 µL methanol,
4.8 µL methanol, 2.4 µL alkaloids from GAN-1F (female frog from Gandoca), 4.8 µL
alkaloids from GAN-1F, 2.4 µL alkaloids from GAN-2M (male frog from Gandoca), and
4.8 µL alkaloids from GAN-2M. GAN-1F and GAN-2M were selected because they
differed in alkaloid quantity, with GAN-1F (280 µg) having a lower quantity of alkaloids
compared to GAN-2M (421 µg). Different frogs from the previous pilot were used in
order to limit the quantity of alkaloids used from individual frogs, given the limited
amount of frog alkaloids available for the experiment. The results from this pilot assay
are in line with previous pilots in that 2.4 µL methanol did not inhibit growth
significantly compared to untreated A. hydrophila (Appendix 6). The results also indicate
that frogs with relatively high quantities of alkaloids (GAN-2M in this case) inhibit
growth of A. hydrophila compared to methanol alone and compared to frogs with
relatively low quantities of alkaloids (GAN-1F here). This is most apparent in volumes of
2.4 µL, where alkaloids from GAN-2M were visibly more inhibitory than methanol and
alkaloids from GAN-1F. Although alkaloid inhibition may not be as apparent at volumes
of 4.8 µL, both frogs’ alkaloids resulted in OD620 measurements that were slightly below
growth with 4.8 µL methanol alone.
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Aeromonas hydrophila CFU Pilot Assays
In order to determine the number of serial dilutions required to obtain single colonies
from growing 10 µL aliquots of Aeromonas hydrophila on TSA, pilot CFU assays were
conducted following the first five pilots, including four 24.5-hour OD pilot assays and the
first pilot examining mid-log addition of treatments. In the first four pilots, two
subsamples of each treatment were serially diluted seven times and plated on TSA in 10
µL aliquots. In the fifth pilot, all three subsamples used were serially diluted seven times
and then plated on TSA in 10 µL aliquots. The overall conclusion from serial dilution
pilots is that a minimum of six serial dilutions is generally required to observe single
colonies below 30 CFUs per aliquot. Additionally, greater volumes of methanol appear to
result in lower CFU counts, suggesting that viability of A. hydrophila cells decreases with
exposure to methanol, which is consistent with results from pilot OD assays. Regarding
CFU counts for the fifth pilot, which compared initial addition and mid-log addition of
2.4 µL and 4.8 µL methanol, the average CFU count parallels trends in the OD assay
almost exactly: mid-log addition of methanol resulted in growth comparable to growth in
the absence of methanol, while initial addition of 2.4 µL methanol resulted in increased
growth and initial addition of 4.8 µL methanol resulted in decreased growth (Appendix 4
and 7).

Klebsiella pneumoniae OD Pilot Assays
Three replicated pilot assays comparing growth curves of 1:5, 1:10, and 1:50 dilutions in
the absence of methanol, with 2.4 µL methanol, and with 4.8 µL methanol were carried
out to determine the optimal dilution of K. pneumoniae to use in OD assays with
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alkaloids. Similarly to previous pilot OD assays with A. hydrophila, eight 200 µL
subsamples for each treatment were plated in a microplate and OD620 was measured at
15-minute intervals over 24.5 hours. All three pilot assays produced nearly identical
growth curves for each treatment at each dilution (Appendix 8). Similar to pilot results
with A. hydrophila, the 1:5 dilution treatments began and ended with the highest OD620,
the 1:10 dilution began and ended intermediately at OD620, and the 1:50 dilution began
and ended with the lowest OD620 values. Once again, a dose-response relationship was
observed with methanol treatments, where the addition of 4.8 µL methanol reduced
OD620 more than 2.4 µL methanol after 24.5 hours. At all dilutions, the addition of 2.4 µL
methanol appears to reduce OD620 compared to treatments with no methanol added,
which was not always apparent with A. hydrophila. Growth curves of the 1:50 dilution
appeared to start just prior to log phase, which made it the least ideal for growth
inhibition assays of the three dilutions. Between the 1:5 and 1:10 dilutions, the 1:5
dilution was selected for use in assays with alkaloids on the grounds that its growth curve
after 24.5 hours was nearer to leveling off (stationary phase) than the 1:10 dilution. Pilot
CFU assays also played a role in selecting the 1:10 dilution for alkaloid assays. In
practice, using either of the 1:5 or 1:10 dilutions did not make a difference in terms of
growth inhibition results.

Klebsiella pneumoniae CFU Pilot Assays
Pilot CFU assays were carried out immediately following pilot OD assays for K.
pneumoniae, and similar trends were observed to those in A. hydrophila pilot CFU
assays. CFUs from 1:5 dilutions consistently required seven serial dilutions in the
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absence of methanol and with the addition of both 2.4 µL and 4.8 µL methanol. The 1:10
dilution yielded CFUs below 30 in number only when methanol was added, but not in
every case, and the 1:50 dilution showed considerable variation around which serial
dilution yielded CFUs under 30 in number. Therefore, the 1:5 dilution was selected as
most suitable for growth inhibition assays because the number of required serial dilutions
was consistent and most similar to those conducted in A. hydrophila assays. Moreover,
since the magnitude of difference between serial dilutions was factored into the original
cell density equations used to report CFU assay results, using the 1:5 resulted in the least
potential variation in original cell density.

Batrachochytrium dendrobatidis (Chytrid Fungus) Culture and Pilots
Culture and Maintenance of Batrachochytrium dendrobatidis
Batrachochytrium dendrobatidis (JEL 197, type strain isolated from an infected green
and black poison frog (Dendrobates auratus) (Longcore et al., 1999)) was received from
Alessandro Catenazzi (Southern Illinois University, Carbondale) on 1% tryptone agar.
Main stock cultures were grown in 1% tryptone broth (Fisher BioReagents, Thermo
Fisher Scientific, Waltham, MA) at 20°C – 22°C for ten days and then stored at 4°C.
Stock cultures (500 mL) were passaged monthly.
For pilot assays, working stocks were produced by growing aliquots of stock Bd
cultures in 1% tryptone broth in 50 mL conical tubes for under one week to ensure that
cells were in an active phase of growth. When isolating zoospores from zoosporangia, 2 –
3 mL of working stock broth cultures were added to 1% tryptone agar in petri dishes
(Fisherbrand, Thermo Fisher Scientific, Waltham, MA). Inoculated dishes were left open
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in the laminar flow hood for 45 – 60 minutes, or until the broth had almost entirely
evaporated. Dishes were then sealed with Parafilm® M (American National Can,
Chicago, IL) and incubated at 20°C – 22°C for 3 – 7 days.
Active zoospores were identified by inverting the dishes on a compound
microscope (Olympus CX21, Olympus, Center Valley, PA) and examining with the 10X
objective. Zoospores were harvested by flooding 3 – 7 day old inoculated dishes with 2 –
3 mL sterile 1% tryptone broth or deionized water for 30 minutes. The solution
containing active zoospores was then passed over sterile nylon mesh filters (20 µm) to
remove zoosporangia. Bd zoospores were intended to be assayed as opposed to a solution
containing both zoospores and mature zoosporangia, because zoospores are the infectious
stage of Bd (Berger et al. 2005) and would be the first to come into contact with alkaloidbased defenses of poison frogs. Therefore, alkaloid-zoospore assays are the most
appropriate first step towards studying the ecological interactions of Bd with alkaloids.
Zoospores were counted using a hemacytometer (Reichert-Jung Bright-Line, Hausser
Scientific, Horsham, PA).
The first pilot for Bd sought to determine a typical growth curve of the unfiltered
1% tryptone broth culture in the absence of methanol, with 2.4 µL methanol, and with 4.8
µL methanol. Similarly to pilot OD assays with bacteria, 200 µL subsamples of 1:5
diluted Bd from a main stock were plated in a microplate with eight subsamples per
treatment: two control samples (i.e., two columns with eight replicates each) of Bd in the
absence of methanol, one sample of Bd inoculated with 2.4 µL methanol, and one sample
of Bd inoculated with 4.8 µL methanol. Optical density measurement filters on the Fisher
Scientific Multiskan FC microplate reader allowed measurement at 405 nm, 450 nm, 550
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nm, and 620 nm; the lowest (OD405) and highest (OD620) wavelengths were used to
measure growth. Due to the prolonged growth period of Bd, this assay ran for seven days;
since the microplate reader is limited to 100 measurements per assay, seven consecutive
runs of 24-hour programs that measured OD405 and OD620 at 15-minute intervals were
carried out. Based on the optical density measurements over seven days (Appendix 9),
growth of Bd at this dilution is clearly very slow, and would undoubtedly have continued
to increase past the end of this assay (as shown in the second Bd pilot). Methanol also
clearly inhibits the growth of Bd, and there is an evident dose-response relationship
between inoculation with 2.4 µL and 4.8 µL methanol. Additionally, there are regular
four- to six-hour fluctuations in OD throughout the assay, although this does not appear
to be typical in Bd growth (Alessandro Catenazzi, pers. comm.). Finally, the growth
curves of replicate treatments measured at 405 nm and 620 nm showed identical growth
patterns, but OD measurements at lower wavelengths seemed to distinguish greater
differences between treatments. As a result, 405 nm was selected as the ideal wavelength
to use in OD assays with Bd. However, most antimicrobial peptide assays with Bd use a
492 nm wavelength filter for similar OD assays, which were unavailable, so it may be
worthwhile to locate a 492 nm filter for the Fisher Scientific Multiskan FC microplate
reader.
In order to characterize the growth of Bd after one week, the treatments for the
first pilot experiment was replicated and Bd growth was measured over the course of 14
days. The program measured OD405 at 4-hour intervals. The results of this second pilot
showed a very similar growth pattern in which growth starts to become noticeable
between 72 and 96 hours (Appendix 10) suggest that Bd growth curves can be relatively
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consistent. However, the initial OD405 was slightly reduced compared to initial OD405 in
the first pilot (about 0.12 OD compared to 0.13 OD), and this difference appears to be
retained in similar proportion at the end of the assay. For example, in this second pilot,
the OD405 after 168 hours was about 0.19 for non-methanol treatments and 0.25 at the end
of the second pilot (i.e., after 336 hours), whereas OD405 for the same treatments in the
first pilot after 168 hours was nearly 0.23. Clearly, small differences in OD at the outset
of Bd assays can result in substantial differences in growth after one and two weeks,
which has the potential to confound comparisons between different assays. Moreover,
since Bd grows so slowly, maintaining a consistent starting OD is likely the primary
methodological challenge, especially if using only zoospores.
Bd zoospores were successfully isolated from cultured zoosporangia and counted
on a hemacytometer, although no growth curves were generated from exploratory
experiments. A variety of methodological difficulties were encountered throughout pilot
experimentation with Bd. For example, the culture media (1% tryptone) was determined
to react with iodine used in killing and staining of motile zoospores, which is highly
useful in counting zoospores to estimate the quantity of zoospores per mL solution. The
reaction between tryptone and iodine produced dense clouds of red-brown, rapidlyvibrating objects that were several times larger than zoospores, but also gradually
reduced their movement and settled onto the hemacytometer surface as if they had been
stained and killed. This reaction did not occur between iodine and sterile water, however,
which would likely be the best solution to count zoospores in. Alternatively, there are a
variety of other dyes available (e.g., trypan blue, although only dead zoospores absorb the
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dye (McMahon and Rohr, 2014)) that may be worthwhile to invest in for counting
zoospores.
Zoospores were rarely isolated in densities exceeding 5 × 105 zoospores/mL,
which is near the lower limit for accurate counting on the hemacytometer. To acquire
higher zoospore densities, denser mats of Bd zoosporangia on multiple agar plates (but no
more than 20 should be fit in the hood, spread out with lids off) must be cultured.
Accordingly, liquid cultures of Bd must also be dense but in an active phase of growth; it
may be useful to plate the settled zoosporangia from liquid cultures, as opposed to
agitating the culture before removing zoosporangia. Similarly, working cultures likely do
not need to be diluted much (e.g., 1:10 in first two Bd pilot experiments).
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Appendix 1. Growth curves of Aeromonas hydrophila from (a) pilot experiment 1 and
(b) pilot experiment 2. Cultures diluted to 1:5, 1:10, and 1:50 had 0 µL, 5 µL, or 10 µL
methanol added. OD620 measurements were recorded at 15-minute intervals over the
course of 24.5 hours.
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Appendix 2. Growth curves of Aeromonas hydrophila from pilot experiment 3. Cultures
diluted to 1:5, 1:10, and 1:50 had 0 µL, 5 µL, or 7.5 µL methanol added. OD620
measurements were recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 3. Growth curves of Aeromonas hydrophila from pilot experiment 4. Cultures
diluted to 1:5, 1:10, and 1:50 had 0 µL, 2.4 µL, or 4.8 µL methanol added. OD620
measurements were recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 4. Growth curves of Aeromonas hydrophila from pilot experiment 5. Cultures
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially or after 1.5 hours of
incubation (“mid-log”). OD620 measurements were recorded at 15-minute intervals over
the course of 24.5 hours. The dotted line represents the point at which mid-log treatments
were added.
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Appendix 5. Growth curves of Aeromonas hydrophila from pilot experiment 6. Cultures
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol or Oophaga pumilio alkaloids
added initially or after 1.5 hours of incubation (“mid-log”). OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours. The dotted line represents
the point at which mid-log treatments were added.
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Appendix 6. Growth curves of Aeromonas hydrophila from pilot experiment 7. Cultures
diluted to 1:10 had 0 µL, 2.4 µL, or 4.8 µL methanol or Oophaga pumilio alkaloids
added. OD620 measurements were recorded at 15-minute intervals over the course of 24.5
hours. The dotted line represents the point at which mid-log treatments were added.
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Appendix 7. Mean colonies formed per 10 µL aliquot from treatments within Aeromonas
hydrophila pilot experiment 5 (1:10 diluted initial culture). Error bars represent ± 1
standard error of the mean, based on three replicates per treatment.
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Appendix 8. Growth curves of Klebsiella pneumoniae from (a) pilot experiment 1, (b)
pilot experiment 2, and (c) pilot experiment 3. Cultures diluted to 1:10 had 0 µL, 2.4 µL,
or 4.8 µL methanol added initially. OD620 measurements were recorded at 15-minute
intervals over the course of 24.5 hours.
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Appendix 9. Growth curves of Batrachochytrium dendrobatidis from pilot experiment 1.
Cultures diluted to 1:5 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially. OD405 and
OD620 measurements were recorded at 1-hour intervals over the course of 7 days.
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Appendix 10. Growth curves of Batrachochytrium dendrobatidis from pilot experiment
2. Cultures diluted to 1:5 had 0 µL, 2.4 µL, or 4.8 µL methanol added initially. OD405
measurements were recorded at 4-hour intervals over the course of 14 days.
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Appendix 11. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 12. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 13. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 14. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
109

Appendix 15. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements
were recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 16. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements
were recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 17. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 18. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 19. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 20. Growth curves of Aeromonas hydrophila treated with (a) 2.4 µL and (b)
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 21. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 22. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Tortuguero Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 23. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 24. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or La Selva Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 25. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements
were recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 26. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Finca los Nacientes Oophaga pumilio alkaloids. OD620 measurements
were recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 27. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours

Appendix 28. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Río Palmas Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 29. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.

Appendix 30. Growth curves of Klebsiella pneumoniae treated with (a) 2.4 µL and (b)
4.8 µL methanol or Gandoca Oophaga pumilio alkaloids. OD620 measurements were
recorded at 15-minute intervals over the course of 24.5 hours.
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Appendix 31. Mass spectral data for the 27 new alkaloids detected in Oophaga pumilio
(Table 3). The Rt for each alkaloid is included, along with an approximate “corrected Rt”
to match the retention times in the alkaloid library of Daly et al. (2005). Following the
methods of Garraffo et al. (2012), based on comparisons of Rts for previously identified
alkaloids in the present study with Rts from Daly et al. (2005), alkaloids in the present
study eluted approximately 0.34 seconds faster than times listed in Daly et al. (2005).
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Unclass 261L
Rt: 12.96
Corrected Rt: 12.62
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4,6-Q 265DD
Rt: 13.30
Corrected Rt: 12.96
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Izi 267BB
Rt: 12.65
Corrected Rt: 12.31
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5,6,8-I 267CC
Rt: 12.80
Corrected Rt: 12.46
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Unclass 267DD
Rt: 13.49
Corrected Rt: 13.15
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Pyr 267EE
Rt: 14.40
Corrected Rt: 14.06
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Unclass 269K
Rt: 11.38
Corrected Rt: 11.04
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Unclass 273F
Rt: 14.88
Corrected Rt: 14.54
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Tri 275L
Rt: 13.92
Corrected Rt: 13.58
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Unclass 275M
Rt: 14.01
Corrected Rt: 13.67
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Pyr 277J
Rt: 14.28
Corrected Rt: 13.94
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Pyr 279M
Rt: 14.33
Corrected Rt: 13.99
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Unclass 281U
Rt: 13.88
Corrected Rt: 13.54
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Unclass 283I
Rt: 15.56
Corrected Rt: 15.22
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Unclass 291K
Rt: 15.75
Corrected Rt: 15.41
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Unclass 311A
Rt: 15.22
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